神経感染症を究める

出版社： 中山書店
著者：
発行日： 2014-12-15
分野： 臨床医学：内科  >  脳神経科学/神経内科学
ISBN： 9784521734460
電子書籍版： 2014-12-15 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

13,200 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

13,200 円(税込)

購入する

商品紹介

神経系感染症の病因は，ウイルス，細菌，真菌，原虫，寄生虫など極めて多彩であり，初期治療が患者の転帰に大きく影響する疾患も数多い．本書では，国内で罹患の可能性のある感染症のみならず輸入感染症についても幅広く網羅し，最新の診断技術や治療法の可能性，免疫低下状態での対応等についてあますところなく言及．神経系感染症にたずさわるすべての人に必携の一冊である．

目次

  • 神経感染症を究める

    ―目次―

    I．総論
    II．ウイルス感染症
    III．細菌感染症
    IV．スピロヘータ感染症
    V．真菌症
    VI．原虫・寄生虫感染症
    VII．プリオン病

    付録
    　感染症法による規制
    　感染症関連ガイドラインと使用上の注意
    　主な抗体検査法　ほか

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I. 総論

P.9 掲載の参考文献
1) 庄司紘史. 神経感染症の特徴 全身症候と神経症候. Clinical Neuroscience 2010 ; 28 : 254-256.
 
2) 海老沢功. 破傷風. 東京 : 日本医事新報社 ; 2005, pp.41-46.
 
3) 西園晃. 狂犬病. BRAIN and NERVE 2009 ; 61 : 135-144.
 
4) 岩田誠. ハンセン病ニューロパチーの臨床. Neuroinfection 2010 ; 15 : 16-21.
 
5) 庄司紘史. ヘルペス脳炎とその周辺. 大阪 : 永井書店 ; 2009, pp.21-25.
 
6) 厚生労働省インフルエンザ脳症研究班 (編). インフルエンザ脳症ガイドライン. 2009, p.6. http://www.mhlw.go.jp/kinkyu/kenkou/influenza/hourei/2009/09/dl/info0925-01.pdf
 
7) 庄司紘史ほか. 単純ヘルペス性辺縁系脳炎. 神経内科 2013 ; 79 : 582-588.
 
8) 江島泰志ほか. 単純ヘルペス脳炎の高齢発症例の検討. 神経内科 2012 ; 77 : 663-665.
 
9) 鈴木馨ほか. 89歳高齢発症の単純ヘルペス脳炎. BRAIN and NERVE 2012 ; 64 : 1063-1068.
 
10) 高橋幸利ほか. 急性辺縁系脳炎におけるグルタミン酸受容体自己免疫の病態. Clinical Neuroscience 2008 ; 26 : 508-511.
 
11) Dalmau J, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007 ; 61 : 25-36.
PubMed
12) Shoji H, et al. Non-herpetic acute limbic encephalitis : A new subgroup of limbic encephalitis. In : Hayasaka D (editor). Pathogenesis of Encephalitis. Croatia : InTech ; 2011, pp.267-278.
 
13) Armangue T, et al. Herpes simplex virus encephalitis is a trigger of brain autoimmunity. Ann Neurol 2014 ; 75 : 317-323.
PubMed
14) 庄司紘史ほか. 脊髄炎・脊髄神経根炎. 別冊日本臨牀, 新領域別症候群シリーズ No.25, 感染症症候群 (第2版) 下. 大阪 : 日本臨牀社 ; 2013, pp.136-139.
 
15) Nagafuchi M, et al. Adult meningism and viral meningitis, 1997-2004 : Clinical data and cerebrospinal fluid cytokines. Intern Med 2006 ; 45 : 1209-1212.
PubMed
16) 庄司紘史. 髄膜刺激症状の診かた. 平山惠造ほか (編). 臨床神経内科学, 改訂5版. 東京 : 南山堂 ; 2006, pp.51-55.
 
17) 田代淳, 田代邦雄. 神経症候, 髄膜刺激徴候. Clinical Neuroscience 2005 ; 23 : 742-743.
 
18) 日本顔面神経研究会 (編). 顔面神経麻痺診療の手引- Bell麻痺とHunt症候群, 2011年版. 東京 : 金原出版 ; 2011, p.9.
 
P.18 掲載の参考文献
1) 青木眞. レジデントのための感染症診療マニュアル, 第2版. 東京 : 医学書院 ; 2008, pp.27-29 (血液培養), pp.391-470 (第V 章 中枢神経感染症).
 
2) 神経系の感染症- Update. Clinical Neuroscience 2010 ; 28 : 254-342.
 
3) 水谷智彦. ウイルス性髄膜炎・脳炎. Clinical Neuroscience 2003 ; 21 : 894-897.
 
4) 水谷智彦. 真菌性髄膜炎. 水澤英洋ほか (編), 今日の神経疾患治療指針, 第2版. 東京 : 医学書院 ; 2013, pp.432-438.
 
5) Fishman RA. Cerebro-spinal Fluid in Diseases of the Nervous System, 2nd edition. Philadelphia : W.B. Saunders ; 1992.
 
6) Roos KL. Lumbar puncture. Semin Neurol 2003 ; 23 : 105-114.
PubMed
7) Studahl M, et al. Acute viral infections of the central nervous system in immunocompetent adults : Diagnosis and management. Drugs 2013 ; 73 : 131-158.
PubMed
8) 小栗豊子 (編). 臨床微生物検査ハンドブック, 第4版. 東京 : 三輪書店 ; 2012.
 
9) Takahashi T, et al. Nested polymerase chain reaction for assessing the clinical course of tuberculous meningitis. Neurology 2005 ; 64 : 1789-1793.
PubMed
10) 高橋輝行ほか. 結核性髄膜炎の遺伝子診断- PCR 法による診断の進歩と今後の展開. 臨床神経学 2013 ; 53 : 1187-1190.
 
・ 高橋輝行ほか. 結核性髄膜炎に対する迅速・高感度診断法. 鈴木則夫ほか (編). Annual Review 神経 2011. 東京 : 中外医学社 ; 2011, pp.150-161.
 
P.25 掲載の参考文献
1) Woese CR, Fox GE. Phylogenetic structure of the prokaryotic domain : The primary kingdoms. Proc Natl Acad Sci U S A 1977 ; 74 : 5088-5090.
PubMed
2) Woese CR. Bacterial evolution. Microbiol Rev 1987 ; 51 : 221-271.
PubMed
3) Raj A, et al. Imaging individual mRNA molecules using multiple singly labeled probes. Nat Methods 2008 ; 5 : 877-879.
PubMed
4) Postollec F, et al. Recent advances in quantitative PCR (qPCR) applications in food microbiology. Food Microbiol 2011 ; 28 : 848-861.
PubMed
5) Kitts CL. Terminal restriction fragment patterns : A tool for comparing microbial communities and assessing community dynamics. Curr Issues Intest Microbiol 2001 ; 2 : 17-25.
PubMed
6) Jany JL, Barbier G. Culture-independent methods for identifying microbial communities in cheese. Food Microbiol 2008 ; 25 : 839-848.
PubMed
7) Stackebrandt E, et al. Bacterial diversity in a soil sample from a subtropical Australian environment as determined by 16S rDNA analysis. FASEB J 1993 ; 7 : 232-236.
 
8) Lane DJ. 16S / 23S rRNA sequencing. In : Stackebrandt E, et al (editors). Nucleic Acid Techniques in Bacterial Systematics. New York, NY : John Wiley and Sons ; 1991, pp.115-175.
 
9) Akiyama T, et al. Development of a novel PCR method to comprehensively analyze salivary bacterial flora and its application to patients with odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010 ; 109 : 669-676.
PubMed
10) Kawanami T, et al. Severe pneumonia with Leptotrichia sp. detected predominantly in bronchoalveolar lavage fluid by use of 16S rRNA gene sequencing analysis. J Clin Microbiol 2009 ; 47 : 496-498.
PubMed
11) Yamasaki K, et al. Significance of anaerobes and oral bacteria in community-acquired pneumonia. PLoS ONE 2013 ; 8 : e63103.
PubMed
12) Yoshimura K, et al. Intravaginal microbial flora by the 16S rRNA gene sequencing. Am J Obstet Gynecol 2011 ; 205 : 235.e1-9.
 
13) Aoki R, et al. Identification of causative pathogens in eyes with bacterial conjunctivitis by bacterial cell count and microbiota analysis. Ophthalmology 2013 ; 120 : 668-676.
PubMed
14) Mardis ER. The impact of next-generation sequencing technology on genetics. Trends Genet 2008 ; 24 : 133-141.
PubMed
15) Weinstock GM. Genomic approaches to studying the human microbiota. Nature 2012 ; 489 : 250-256.
PubMed
・ 服部正平 (監修). メタゲノム解析技術の最前線. 東京 : イーエムシー出版 ; 2010.
 

II. ウイルス感染症

P.33 掲載の参考文献
1) 大石実. Kernig徴候とLasegue徴候. Clinical Neuroscience 2012 ; 30 : 536-537.
 
2) Irani DN. Aseptic meningitis and viral myelitis. Neurol Clin 2008 ; 26 : 635-655.
PubMed
3) 亀井聡. 抗NMDA受容体脳炎. ペインクリニック 2013 ; 34 : 977-985.
Medical*Online
4) Mundiyanapurath S, et al. GABA-B-receptor antibodies in paraneoplastic brainstem encephalitis. J Neuroimmunol 2013 ; 259 : 88-91.
PubMed
5) Rajput D, et al. Recurrent chemical meningitis in craniopharyngioma without reduction in size of cyst : Case report of two cases and review of the literature. Turk Neurosurg 2012 ; 22 : 233-236.
PubMed
6) Komagamine T, et al. Recurrent aseptic meningitis in association with Kikuchi-Fujimoto disease : Case report and literature review. BMC Neurology 2012 ; 12 : 112.
PubMed
7) Poulikakos PJ, et al. A case of recurrent benign lymphocytic (Mollaret's) meningitis and review of the literature. J Infect Public Health 2010 ; 3 : 192-195.
PubMed
8) Kupila L, et al. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 2006 ; 66 : 75-80.
 
9) de Almeida SM, et al. Laboratorial diagnosis of lymphocytic meningitis. Braz J Infect Dis 2007 ; 11 : 489-495.
PubMed
10) Lancaster E, Dalmau J. Neuronal autoantigens -- pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 2012 ; 8 : 380-390.
PubMed
11) Ramanathan S, et al. Autoimmune encephalitis : Recent updates and emerging challenges. J Clin Neurosci 2014 ; 21 : 722-730.
PubMed
12) Huy NT, et al. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis : A systemic review and meta-analysis. Crit Care 2010 ; 14 : R240.
PubMed
13) Sakushima K, et al. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis : A meta-analysis. J Infect 2011 ; 62 : 255-262.
PubMed
14) Wender M. Acute disseminated encephalomyelitis (ADEM). J Neuroimmunol 2011 ; 231 : 92-99.
 
15) Wang J-N, et al. Critical management in patients with severe enterovirus 71 infection. Pediatr Int 2006 ; 48 : 250-256.
PubMed
・ Solomon T, et al. Viral encephalitis : A clinician's guide. Pract Neurol 2007 ; 7 : 288-305.
PubMed
・ Tunkel AR, et al. The management of encephalitis : Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008 ; 47 : 303-327.
 
・ Granerod J, et al. Causality in acute encephalitis : Defining aetiologies. Epidemiol Infect 2010 ; 138 : 783-800.
PubMed
P.43 掲載の参考文献
1) Kamei S, Takasu T. Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Intern Med 2000 ; 39 : 894-900.
PubMed
2) Tan IL, et al. Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised. Neurology 2012 ; 79 : 2125-2132.
PubMed
3) 日本神経感染症学会. ヘルペス脳炎のガイドライン. Neuroinfection 2005 ; 10 : 78-87.
 
4) Solomon T, et al. Viral encephalitis : A clinician's guide. Pract Neurol 2007 ; 7 : 288-305.
PubMed
5) Tunkel AR, et al. The management of encephalitis : Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008 ; 47 : 303-327.
 
6) Kamei S, et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005 ; 76 : 1544-1549.
PubMed
7) Taira N, et al. Predictors of prolonged clinical course in adult patients with herpes simplex virus encephalitis. Intern Med 2009 ; 48 : 89-94.
PubMed
8) Granerod J, et al. Causes of encephalitis and differences in their clinical presentations in England : A multicentre, population-based prospective study. Lancet Infect Dis 2010 ; 10 : 835-844.
 
9) Ambrose HE, et al. Diagnostic strategy used to establish etiologies of encephalitis in a prospective cohort of patients in England. J Clin Microbiol 2011 ; 49 : 3576-3583.
 
10) 石井慶蔵ほか. ウイルス関連神経感染症の疫学. 日本臨牀 1997 ; 55 : 839-848.
Medical*Online
11) Tyler KL. Herpes simplex virus infections of the central nervous system : Encephalitis and meningitis, including Mollaret's. Herpes 2004 ; 11 (Suppl 2) : 57A-64A.
 
12) Aurelius E. Neurological disease in herpes simplex virus type 2 infection. In : Studahl M, et al (editors). Herpes Simplex Viruses. New York : Taylor and Francis Group ; 2006, pp.317-338.
 
13) 中嶋秀人. 単純ヘルペス感染と脊髄炎. Annual Review神経 2007. 東京 : 中外医学社 ; 2007, pp.106-113.
 
14) Nakajima H, et al. Herpes simplex virus myelitis : Clinical manifestations and diagnosis by the polymerase chain reaction method. Eur Neurol 1998 ; 39 : 163-167.
PubMed
15) 林良一, 大原慎司. Elsberg症候群. Annual Review神経 2004. 東京 : 中外医学社 ; 2004, pp.126-132.
 
16) 中嶋秀人. HSV脊髄炎とElsberg症候群. Clinical Neuroscience 2010 ; 28 : 336-337.
 
・ 日本神経感染症学会 (編). ヘルペス脳炎-診療ガイドラインに基づく診断基準と治療指針. 東京 : 中山書店 ; 2006.
 
・ 庄司紘史. ヘルペス脳炎とその周辺. 大阪 : 永井書店 ; 2009.
 
P.51 掲載の参考文献
1) Persson A, et al. Varicella-zoster virus CNS disease--Viral load, clinical manifestations, and sequels. J Clin Virol 2009 ; 46 : 249-253.
PubMed
2) Pollak L, et al. Varicella zoster vs. herpes simplex meningoencephalitis in the PCR era. A single center study. J Neurol Sci 2012 ; 314 : 29-36.
 
3) Corral I, et al. Neurological complications of varicella-zoster virus in human immunodeficiency virus-infected patients : Changes in prevalence and diagnostic utility of polymerase chain reaction in cerebrospinal fluid. J Neurovirol 2003 ; 9 : 129-135.
PubMed
4) Aberle SW, et al. Quantitative real time PCR detection of varicella-zoster virus DNA in cerebrospinal fluid in patients with neurological disease. Med Microbiol Immunol 2005 ; 194 : 7-12.
PubMed
5) Nagel MA, et al. The value of detecting anti-VZV antibody in CSF to diagnose VZV vasculopathy. Neurology 2007 ; 68 : 1069-1073.
PubMed
6) 樋口由美子, 森嶋隆文. 帯状疱疹にみられる髄膜炎現象に関する研究. 日皮会誌 1988 ; 98 : 721-730.
 
7) De La Blanchardiere A, et al. Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection. Scand J Infect Dis 2000 ; 32 : 263-269.
PubMed
8) Kupila L, et al. Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 2006 ; 66 : 75-80.
 
9) 亀井聡. 神経系感染症の疫学. 神経研究の進歩 1999 ; 43 : 5-13.
 
10) Pahud BA, et al. Varicella zoster disease of the central nervous system : Epidemiological clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis 2011 ; 203 : 316-323.
PubMed
11) De Broucker T, et al. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 2012 ; 18 : 808-819.
 
12) Becerra JC, et al. Infection of the central nervous system caused by varicella zoster virus reactivation : A retrospective case series study. Int J Infect Dis 2013 ; 17 : e529-534.
PubMed
13) Gilden D, et al. Varicella zoster virus vasculopathies : Diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009 ; 8 : 731-740.
PubMed
14) Doyle PW, et al. Herpes zoster ophthalmicus with contralateral hemiplegia : Identification of cause. Ann Neurol 1983 ; 14 : 84-85.
PubMed
15) Hung CH, et al. Features of varicella zoster virus myelitis and dependence on immune status. J Neurol Sci 2012 ; 318 : 19-24.
 
16) Mondelli M, et al. Herpes zoster of the head and limbs : Electroneuromyographic and clinical findings in 158 consecutive cases. Arch Phys Med Rehabil 2002 ; 83 : 1215-1221.
PubMed
17) Opstelten W, et al. Herpes zoster and postherpetic neuralgia : Incidence and risk indicators using a general practice research database. Fam Pract 2002 ; 19 : 471-475.
 
18) Solomon T, et al. Management of suspected viral encephalitis in adults-Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012 ; 64 : 347-373.
 
19) Oxman MN, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005 ; 352 : 2271-2284.
PubMed
20) Lewis GW. Zoster sine herpete. Br Med J 1958 ; 16 : 418-421.
 
P.59 掲載の参考文献
1) 今留謙一. EBV-T/NK-LPD (CAEBV, EBV-HLH etc.) の病態と診断. 臨床血液 2013 ; 54 : 1992-1998.
 
2) 木村宏. 慢性活動性EBV感染症. ウイルス 2011 ; 61 : 163-174.
 
3) Miyashita T, et al. Epstein-Barr virus-associated meningitis presenting with hearing impairment. Intern Med 2012 ; 51 : 1755-1757.
PubMed
4) Hashimoto Y, et al. Leptomeningeal enhancement in acute cerebellitis associated with Epstein-Barr virus. Intern Med 2008 ; 47 : 331-332.
PubMed
5) Kobayashi Z, et al. An autopsy case of chronic active Epstein-Barr virus infection (CAEBV) : Distribution of central nervous system (CNS) lesions. J Neurol Sci 2008 ; 275 : 170-177.
PubMed
6) 多屋馨子. 伝染性単核症. http://idsc.nih.go.jp/idwr/kansen/k03/k03_23/k03_23.html
 
7) Kimura H, et al. Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol 2000 ; 188 : 197-202.
PubMed
8) Volpi A. Epstein-Barr virus and human herpesvirus type 8 infections of the central nervous system. Herpes 2004 ; 11 (Suppl 2) : 120A-127A.
 
9) 木村宏. EBウイルス関連T / NKリンパ増殖性疾患に関する最新知見. 小児感染免疫 2012 ; 24 : 291-295.
 
10) 今宿晋作ほか. ヘルペスウイルス感染と血球貪食症候群. 日本臨牀 2006 ; 64 (増刊号 3) : 663-667.
 
11) 今宿晋作ほか. EBウイルス関連血球貪食性リンパ組織球増殖症 (EBV-HLH). 炎症と免疫 2003 ; 11 : 302-308.
Medical*Online
12) 津田弘之. ウイルス関連血球貪食症候群. ウイルス 2002 ; 52 : 233-238.
 
13) Tunkel AR, et al. The management of encephalitis : Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008 ; 47 : 303-327.
 
14) Uchibori A, et al. Autoantibodies in postinfectious acute cerebellar ataxia. Neurology 2005 ; 65 : 1114-1116.
PubMed
15) Majid A, et al. Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain 2002 ; 125 : 159-165.
PubMed
16) 越智雅之ほか. Epstein-Barrウイルスによる髄膜脊髄神経根炎後, 再発性に横断性脊髄炎と複視をきたした1例. 臨床神経学 2007 ; 47 : 348-352.
 
17) Takahashi K, et al. Guillain-Barre syndrome and hemophagocytic lymphohistiocytosis in a patient with severe chronic active Epstein-Barr virus infection syndrome. Clin Neurol Neurosurg 2005 ; 108 : 80-83.
 
18) 荒木克哉ほか. 小脳性運動失調と多形紅斑が共に増悪と寛解をくりかえした慢性活動性Epstein-Barrウイルス感染症の1例. 臨床神経学 2013 ; 53 : 119-124.
 
19) Cavaliere R, et al. Primary central nervous system post-transplantation lymphoproliferative disorder : An International Primary Central Nervous System Lymphoma Collaborative Group Report. Cancer 2010 ; 116 : 863-870.
 
20) 笹川淳ほか. AIDS関連中枢神経原発悪性リンパ腫発生におけるリンパ球機能関連抗原 (LFA-1) の関与. 近畿大医誌 2012 ; 37 : 45-52.
 
P.63 掲載の参考文献
1) Saliba WR, et al. Cytomegalovirus encephalitis in an immunocompetent pregnant woman. Eur J Clin Microbiol Infect Dis 2004 ; 23 : 563-566.
 
2) Rafailidis PI, et al. Severe cytomegalovirus infection in apparently immunocompetent patients : A systematic review. Virol J 2008 ; 5 : 47. http://www.virologyj.com/content/5/1/47
 
3) 木村英紀ほか. CMV 脳炎. Clinical Neuroscience 2010 ; 28 : 278-279.
 
4) Bolovan-Fritts CA, et al. Peripheral blood CD14 (+) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 1999 ; 93 : 394-398.
PubMed
5) Kondo K, et al. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc Natl Acad Sci U S A 1994 ; 91 : 11879-11883.
PubMed
6) 干場勉ほか. βヘルペスウイルスの抗体保有率. 日本臨牀 2006 ; 64 : 451-454.
Medical*Online
7) 多屋馨子. サイトメガロウイルス感染症. 日本臨牀 2005 ; 63 増刊号 4 : 528-533.
 
8) Kato T, et al. Neuropathology of acquired immune deficiency syndrome (AIDS) in 53 autopsy cases with particular emphasis on microglial nodules and multinucleated giant cells. Acta Neuropathol 1987 ; 73 : 287-294.
PubMed
9) Griffiths P. Cytomegalovirus infection in the central nervous system. Herpes 2004 ; 11 (Suppl 2) : 95A-104A.
 
10) Silva CA, et al. Neurologic cytomegalovirus complications in patients with AIDS : Retrospective review of 13 cases and review of the literature. Rev Inst Med Trop Sao Paulo 2010 ; 52 : 305-310.
PubMed
11) 日本造血細胞移植学会 (編). 造血細胞移植ガイドライン-サイトメガロウイルス感染症, 第2版. www.jshct.com/guideline/pdf/guideline_CMV_2.pdf
 
12) Clifford DB, et al. Magnetic resonance imaging lacks sensitivity for AIDS associated with cytomegalovirus encephalitis. J Neuroviol 1996 ; 2 : 397-403.
PubMed
13) Seok JH, et al. Diffusion MRI findings of cytomegalovirus-associated ventriculitis : A case report. Br J Radiol 2011 ; 84 : e179-e181.
PubMed
P.67 掲載の参考文献
1) Yamanishi K, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988 ; 1 : 1065-1067.
PubMed
2) Zerr DM. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol 2006 ; 37 (Suppl 1) : S52-56.
 
3) Dockrell DH. Human herpesvirus 6 : Molecular biology and clinical features. J Med Microbiol 2003 ; 52 : 5-18.
PubMed
4) Seeley WW, et al. Post-transplant acute limbic encephalitis : Clinical features and relationship to HHV6. Neurology 2007 ; 69 : 156-165.
PubMed
5) Noguchi T, et al. MR imaging of human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation in adults. AJNR Am J Neuroradiol 2006 ; 27 : 2191-2195.
PubMed
6) Ogata M, et al. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation : A multicenter, prospective study. Clin Infect Dis 2013 ; 57 : 671-681.
PubMed
7) Fujimaki K, et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol 2006 ; 84 : 432-437.
PubMed
8) Sashihara J, et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002 ; 100 : 2005-2011.
PubMed
9) Muta T, et al. Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan : A retrospective multicenter study. Bone Marrow Transplant 2009 ; 43 : 583-585.
PubMed
10) Morissette1 G, Flamand L. Herpesviruses and chromosomal integration. J Virol 2010 ; 84 : 12100-12109.
 
11) Yoshikawa T. Human herpesvirus 6 infection in hematopoietic stem cell transplant patients. Br J Haematol 2004 ; 124 : 421-432.
PubMed
12) 牟田毅ほか. 造血幹細胞移植後のHHV-6脳炎. 神経内科 2006 ; 64 : 152-159.
 
P.75 掲載の参考文献
1) Morishima T, et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. Clin Infect Dis 2002 ; 35 (5) : 512-517.
PubMed
2) 森島恒雄. 「新型インフルエンザ」の臨床的特徴. 小児科診療 2011 ; 74 : 1337-1342.
Medical*Online
3) 厚生労働省インフルエンザ脳症研究班. インフルエンザ脳症ガイドライン改訂版. 研究代表者 : 森島恒雄. 2009. http://www.mhlw.go.jp/kinkyu/kenkou/influenza/hourei/2009/09/dl/info0925-01.pdf
 
4) Ichiyama T, et al. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis 2003 ; 35 : 59-61.
PubMed
5) Mizuguchi M, et al. Acute encephalopathy associated with influenza and other viral infections. Acta Neurol Scand 2007 ; 115 : 45-56.
PubMed
6) Hoshino A, et al. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 2012 ; 34 (5) : 337-343.
PubMed
7) 小林慈典ほか. インフルエンザ脳症特殊治療の全国調査. 日本小児科学会雑誌 2007 ; 111 : 659-665.
 
8) Kawano G, et al. Determinants of outcomes following acute child encephalopathy and encephalitis : Pivotal effect of early and delayed cooling. Arch Dis Child 2011 ; 96 : 936-941.
PubMed
9) 中川拓ほか. 脳低温/平温療法は難治性てんかん重積状態で発症する急性脳症による神経学的後遺症を低減する. 脳と発達 2011 ; 43 : 459-463.
Medical*Online
10) 中村俊紀ほか. 重症急性脳症の管理に頭蓋内圧センサは必要か. 日本小児救急医学会雑誌 2011 ; 10 : 225.
 
11) Momonaka H, et al. High mobility group box 1 in patients with 2009 pandemic H1N1 influenzaassociated encephalopathy. Brain Dev 2014 ; 36 : 484?488.
 
12) 藤井洋輔ほか. 脳炎・脳症とバイオマーカー. 小児内科 2013 ; 45 (2) : 187-190.
Medical*Online
13) Yamanaka G, et al. Diagnostic and predictive value of CSF d-ROM level in influenza virus-associated encephalopathy. J Neurol Sci 2006 ; 243 : 71-75.
PubMed
14) 森島恒雄. 小児の急性脳炎・脳症の現状. ウイルス 2009 ; 59 : 59-66.
 
15) 森島恒雄, 長岡義晴. インフルエンザA (H1N1) 2009 (新型インフルエンザ) 脳症全国調査結果. 厚生労働省, 新型インフルエンザ等新興・再興感染症研究事業「インフルエンザ脳症の発症因子の解明とそれに基づく発症前診断の確立に関する研究」平成22年度報告書. 2011, pp.9-12.
 
16) Kawashima H, et al. National survey of pandemic influenza A (H1N1) 2009-associated encephalopathy in Japanese children. J Med Virol 2012 ; 84 : 1151-1156.
 
17) Okumura A, et al. Acute encephalopathy with 2009 pandemic flu : Comparison with seasonal flu. Brain Dev 2012 ; 34 : 13-19.
PubMed
18) 奥村彰久. 新型インフルエンザ小児死亡例の実態調査結果. 厚生労働科学研究費補助金 新型インフルエンザ等新興・再興感染症研究事業「インフルエンザ脳症など重症インフルエンザの発症機序の解明とそれに基づく治療法, 予防法の確立に関する研究」 (研究代表者 : 森島恒雄). 平成22年度報告書. 2011, pp.21-28.
 
P.82 掲載の参考文献
1) 平石克平ほか. 日本脳炎の臨床 最近10年間の自験例を中心として. 神経研究の進歩 1967 ; 11 (2) : 273-292.
 
2) 池田ちずるほか. 日本脳炎の1幼児例. 日児誌 2008 ; 112 (9) : 1390-1397.
 
3) Bista MB, et al. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis : A case control study. Lancet 2001 ; 358 : 791-795.
PubMed
4) Lanciotti RS, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999 ; 286 (5448) : 2333-2337.
PubMed
5) Chaskopoulou A, et al. Detection and early warning of West Nile Virus circulation in Central Macedonia, Greece, using sentinel chickens and mosquitoes. Vector Borne Zoonotic Dis 2013 ; 13 (10) : 723-732.
PubMed
6) Hayes EB, et al. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 2005 ; 11 (8) : 1167-1173.
PubMed
7) Centers for Disease Control and Prevention (CDC). Possible dialysis-related west nile virus transmission--Georgia, 2003. MMWR Morb Mortal Wkly Rep 2004 ; 53 (32) : 738-739.
PubMed
8) Pile J. West Nile fever : Here to stay and spreading. Cleve Clin J Med 2001 ; 68 : 553-560.
PubMed
9) Weiss D, et al. Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis 2001 ; 7 : 654-658.
PubMed
10) Rosas H, Wippold FJ II. West Nile virus : Case report with MR imaging findings. AJNR Am J Neuroradiol 2003 ; 24 : 1376-1378.
 
11) Takashima I, et al. A case of tick-borne encephalitis in Japan and isolation of the virus. J Clin Microbiol 1997 ; 35 : 1943-1947.
PubMed
12) 国立感染症研究所. 感染症発生動向調査週報. 2002 ; 4 (3) : 11.
 
13) Chiba N. et al. Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization. Vaccine 1999 ; 17 : 1532-1539.
PubMed
14) Labuda M, et al. Tick-borne encephalitis virus foci in Slovakia. Int J Med Microbiol 2002 ; 291 (Suppl 33) : 43-47.
 
15) Solomon T, et al. Neurological manifestations of dengue infection. Lancet 2000 ; 355 (9209) : 1053-1059.
PubMed
P.85 掲載の参考文献
1) Croser EL, Marsh GA. The changing face of the henipaviruses. Vet Microbiol 2013 ; 167 : 151-158.
PubMed
2) Luby SP. The pandemic potential of Nipah virus. Antiviral Res 2013 ; 100 : 38-43.
PubMed
3) Eaton BT, et al. Hendra and Nipah viruses : Different and dangerous. Nat Rev Microbiol 2006 ; 4 : 23-35.
PubMed
4) Sendow I, et al. Henipavirus in Pteropus vampyrus bats, Indonesia. Emerg Infect Dis 2006 ; 12 : 711-712.
PubMed
5) Wacharapluesadee S, et al. Bat Nipah virus, Thailand. Emerg Infect Dis 2005 ; 11 : 1949-1951.
PubMed
6) Olson JG, et al. Antibodies to Nipah-like virus in bats (Pteropus lylei), Cambodia. Emerg Infect Dis 2002 ; 8 : 987-988.
PubMed
7) Aljofan M. Hendra and Nipah infection : Emerging paramyxoviruses. Virus Res 2013 ; 177 : 119-126.
PubMed
8) Luby SP, et al. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001-2007. Emerg Infect Dis 2009 ; 15 : 1229-1235.
PubMed
P.91 掲載の参考文献
1) Jackson A C, Wunner WH (editors). Rabies, 2nd Edition. Great Britain : Academic Press, Elsevier Science Imprint ; 2007.
 
2) Rupprecht CE, et al. Rabies re-examined. Lancet Infect Dis 2002 ; 2 (6) : 327-343.
PubMed
3) Warrell MJ, Warrell DA. Rabies and other lyssavirus diseases. Lancet 2004 ; 363 (9413) : 959-969.
PubMed
4) Srinivasan A, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005 ; 352 : 1103-1111.
PubMed
5) World Health Organization. WHO Expert Consultation on Rabies, First Report. Geneva : WHO ; 2005.
 
6) Willoughby RE Jr, et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005 ; 352 (24) : 2508-2514.
 
7) Hemachudha T, et al. Failure of therapeutic coma and ketamine for therapy of human rabies. J Neurovirol 2006 ; 12 (5) : 407-409.
PubMed
P.98 掲載の参考文献
1) 山本悌司. ポリオウイルス感染症 (ポリオ). 別冊日本臨牀, 新領域別症候群シリーズ No.24, 感染症症候群 (第2版) 上. 大阪 : 日本臨牀社 ; 2013, pp.392-399.
 
2) 奥田文吾. ポリオウイルス1-3 型. 別冊日本臨牀, 新領域別症候群シリーズ No.26, 神経症候群 (第2版) I. 大阪 : 日本臨牀社 ; 2014, pp.568-571.
 
3) 大原義朗. 急性灰白髄炎 (ポリオ). 井村裕夫ほか (編), 最新内科学大系 67, 神経感染症と脱髄疾患. 東京 : 中山書店 ; 1996, pp.123-127.
 
4) 宮村達男. 日本のポリオ. IASR 2000 ; 21 : 214-216.
 
5) Wild Poliovirus 2009-2014. http://www.polioeradication.org/Portals/0/Document/Data&Monitoring/Wild_poliovirus_list_2009_2014_15Apr.pdf
 
6) 大岡静衣. ポリオウイルスの体内伝播機構解析. ウイルス 2009 ; 59 : 107-114.
 
7) 山本悌司ほか. ポリオ臨床診断マニュアル-我国から2000年までにポリオを根絶するために. 臨床とウイルス 2000 ; 28 : 116-128.
Medical*Online
8) 厚生労働省ホームページ予防接種情報・ポリオワクチン. http://www.mhlw.go.jp/bunya/kenkou/polio/dl/leaflet_120601.pdf
 
9) Hao L, et al. Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000. Jpn J Infect Dis 2008 ; 61 : 100-103.
PubMed
10) Cherry JD, et al. Enteroviruses and paraechoviruses. In : Feigin RD, et al (editors). Feigin & Cherry's Textbook of Pediatric Infectious Diseases, 6th edition. Philadelphia : WB Saunders ; 2009, pp.2110-2170.
 
11) IASR (病原微生物検出情報) 無菌性髄膜炎由来ウイルス・週別2010～2014 年. https://nesid3g.mhlw.go.jp/Byogentai/Pdf/data16j.pdf
 
12) 市山高志. コクサッキーウイルス. 別冊日本臨牀, 新領域別症候群シリーズ No.26, 神経症候群 (第2版) I. 大阪 : 日本臨牀社 ; 2014, pp.576-577.
 
13) Berger JR, et al. Coxsackie B meningoencephalitis in a patient with acquired immunodeficiency syndrome and multiple sclerosis-like illness. J Neurovirol 2009 ; 15 : 282-287.
 
14) 法化図陽一. エンテロウイルス71 型. 別冊日本臨牀, 新領域別症候群シリーズ No.26, 神経症候群 (第2版) I. 大阪 : 日本臨牀社 ; 2014, pp.572-575.
 
15) IASR (病原微生物検出情報) 手足口病由来ウイルス・週別2010～2014年. https://nesid3g.mhlw.go.jp/Byogentai/Pdf/data24j.pdf
 
16) 塩見正司ほか. エンテロウイルス71による脳幹脳炎. 小児内科 2004 ; 36 : 1191-1195.
 
17) 吉田茂ほか. 中枢神経症状を伴う手足口病の臨床的検討. 日児誌 2003 ; 107 : 473-479.
 
18) Liang Z, et al. Progress on the research and development of human enterovirus 71 (EV71) vaccines. Front Med 2013 ; 7 : 111-121.
PubMed
19) 清水博之. 手足口病 (エンテロウイルス71) ワクチン開発の現状. IASR 2012 ; 33 : 65-66.
 
20) Zhu FC, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China : A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013 ; 381 : 2024-2032.
 
・ Polio Eradication and Endgame Strategic plan 2013-2018. http://www.polioeradication.org/Resourcelibrary/Strategyandwork.aspx
 
・ Ooi MH, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010 ; 9 : 1097-1105.
PubMed
P.106 掲載の参考文献
1) Takahashi T, et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis 2014 ; 209 (6) : 816-827.
PubMed
2) Timen A, et al. Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis 2009 ; 15 (8) : 1171-1175.
PubMed
3) Hirabayashi Y, et al. An imported case of Lassa fever with late appearance of polyserositis. J Infect Dis 1988 ; 158 (4) : 872-875.
PubMed
4) Nichol ST, et al. Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science 1993 ; 262 (5135) : 914-917.
PubMed
5) Gai ZT, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis 2012 ; 206 (7) : 1095-1102.
PubMed
6) 山岸拓也ほか. 2013年に発症した重症熱性血小板減少症候群40例のまとめ-感染症発生動向調査より. 病原微生物検出情報 (IASR) 2014 ; 35 (2) : 38-39.
 
7) 森川茂ほか. ウイルス性出血熱と日本における検査体制. ウイルス 2001 ; 51 (2) : 215-224.
 
8) Saijo M, et al. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever. Clin Vaccine Immunol 2007 ; 14 (9) : 1182-1189.
PubMed
9) Saijo M, et al. Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins. Clin Vaccine Immunol 2006 ; 13 (4) : 444-451.
PubMed
10) Saijo M, et al. Antigen-capture enzyme-linked immunosorbent assay for the diagnosis of crimeancongo hemorrhagic fever using a novel monoclonal antibody. J MedVirol 2005 ; 77 (1) : 83-88.
PubMed
11) Saijo M, et al. Recombinant nucleoprotein-based serological diagnosis of Crimean-Congo hemorrhagic fever virus infections. J Med Virol 2005 ; 75 (2) : 295-299.
PubMed
12) Ure AE, et al. Argentine hemorrhagic fever diagnostic test based on recombinant Junin virus N protein. J Med Virol 2008 ; 80 (12) : 2127-2133.
 
13) McCormick JB, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med 1986 ; 314 (1) : 20-26.
PubMed
P.111 掲載の参考文献
1) Abe Y, et al. Survey of subacute sclerosing panencephalitis in Japan. J Child Neurol 2012 ; 27 : 1529-1533.
PubMed
2) Inoue T, et al. Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 2002 ; 59 : 822-827.
PubMed
3) Torisu H, et al. Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis. Neurology 2004 ; 62 : 457-460.
PubMed
4) Abe Y, et al. Characteristics of viruses derived from nude mice with persistent measles virus infection. J Virol 2013 ; 87 : 4170-4175.
PubMed
5) Jabbour J, et al. SSPE : Clinical, staging, course, and frequency. Arch Neurol 1975 ; 32 : 493-494.
 
6) Huttenlocher PR, Mattson RH. Isoprinosine in subacute sclerosing panencephalitis. Neurology 1979 ; 29 : 763-771.
PubMed
7) Haddad FS, Risk WS. Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis : A controlled study. Ann Neurol 1980 ; 7 : 185-188.
PubMed
8) Dyken PR, et al. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with inosiplex. Ann Neurol 1982 ; 11 : 359-364.
PubMed
9) Jones CE, et al. Inosiplex therapy in subacute sclerosing panencephalitis. A multicentre, nonrandomised study in 98 patients. Lancet 1982 ; 1 (8280) : 1034-1037.
PubMed
10) DuRant RH, et al. The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis. J Pediatr 1982 ; 101 : 288-293.
PubMed
11) Yalaz K, et al. Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis. Neurology 1992 ; 42 : 488-491.
PubMed
12) Gascon G, et al. Combined oral isoprinosine-intraventricular alpha-interferon therapy for subacute sclerosing panencephalitis. Brain Dev 1993 ; 15 : 346-355.
PubMed
13) Anlar B, et al. Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular alpha-interferon. Neurology 1997 ; 48 : 526-528.
PubMed
14) Hosoya M, et al. High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. Antimicrob Agents Chemother 2001 ; 45 : 943-945.
PubMed
15) Tomoda A, et al. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis. Pediatr Neurol 2001 ; 24 : 54-59.
PubMed
16) Hosoya M, et al. Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis. Antimicrob Agents Chemother 2004 ; 48 : 4631-4635.
PubMed
P.120 掲載の参考文献
1) 厚生労働科学研究費補助金 難治性疾患克服研究事業「プリオン病及び遅発性ウイルス感染症に関する調査研究班」 (編). プリオン病と遅発性ウイルス感染症. 東京 : 金原出版 ; 2010, pp.1-333.
 
2) Tan CS, Koralnik IJ. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus : Clinical features and pathogenesis. Lancet Neurol 2010 ; 9 : 425-437.
PubMed
3) 厚生労働科学研究費補助金 難治性疾患等克服研究事業「プリオン病及び遅発性ウイルス感染症に関する調査研究班」 (研究代表者山田正仁). 進行性多巣性白質脳症 (Progressive Multifocal Leukoencephalopathy : PML) 診療ガイドライン 2013. http://prion.umin.jp/file/PML2013.pdf
 
4) 高尾昌樹. 分子標的薬とPML-モノクローナル抗体療法時代のPML. BRAIN and NERVE 2013 ; 65 : 1363-1374.
 
5) Taguchi F, et al. Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 1982 ; 26 : 1057-1064.
PubMed
6) Brew BJ, et al. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol 2010 ; 6 : 667-679.
PubMed
7) 岸田修二. PMLの疫学と臨床. BRAIN and NERVE 2007 ; 59 : 125-137.
 
8) Bloomgren G, et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 2012 ; 366 : 1870-1880.
PubMed
9) Nakamichi K, et al. Evaluation of a quantitative real-time PCR assay for the detection of JC polyomavirus DNA in cerebrospinal fluid without nucleic acid extraction. Jpn J Infect Dis 2011 ; 64 : 211-216.
PubMed
10) Shah R, et al. Imaging manifestations of progressive multifocal leukoencephalopathy. Clin Radiol 2010 ; 65 : 431-439.
PubMed
11) Antinori A, et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy : Data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003 ; 9 (Suppl 1) : 47-53.
 
12) Crowder CD, et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transplant 2005 ; 5 : 1151-1158.
 
13) Clifford DB, et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis : Lessons from 28 cases. Lancet Neurol 2010 ; 9 : 438-446.
PubMed
14) Tan K, et al. PML-IRIS in patients with HIV infection : Clinical manifestations and treatment with steroids. Neurology 2009 ; 72 : 1458-1464.
PubMed
P.128 掲載の参考文献
1) 三浦義治, 岸田修二. HIV感染に伴う神経疾患. BRAIN and NERVE 2013 ; 65 : 275-281.
 
2) Schouten J, et al. HIV-1 infection and cognitive impairment in the cART era : A review. AIDS 2011 ; 25 : 561-575.
 
3) Miura Y, et al. Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection. Proc Natl Acad Sci U S A 2003 ; 100 (5) : 2777-2782.
 
4) Miura Y, et al. TNF-related apoptosis-inducing ligand (TRAIL) induces neuronal apoptosis in HIVencephalopathy. J Med Dent Sci 2003 ; 50 (1) : 17-25.
PubMed
5) Kaul M, et al. HIV-1 infection and AIDS : Consequences for the central nervous system. Cell Death Differ 2005 ; 12 (Suppl 1) : 878-892.
 
6) 鈴木直人ほか. 厚生労働科学研究費補助金エイズ対策研究事業「NeuroAIDS の発症病態と治療法の開発を目指した長期フォローアップ体制の構築研究」班 (班長中川正法). HIV感染者高次脳機能評価バッテリーの作成. 平成18年度総括・分担研究報告. 2007, pp.7-14.
 
7) Letendre S, et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008 ; 65 : 65-70.
PubMed
8) Silber E, et al. Meningitis in a community with a high prevalence of tuberculosis and HIV infection. J Neurol Sci 1999 ; 162 : 20-26.
 
9) 岸田修二. AIDS患者で見られる末梢神経障害. Modern Physician 1998 ; 18 : 725-728.
 
10) Brew BJ, Tomlinson SE. HIV neuropathy : Time for new therapies. Drug Discovery Today : Disease Models 2004 ; 1 (2) : 171-176.
 
11) Pinto AN. AIDS and cerebrovascular disease. Stroke 1996 ; 27 : 538-543.
PubMed
12) Cole JW, et al. Acquired immunodeficiency syndrome and the risk of stroke. Stroke 2004 ; 35 : 51-56.
PubMed
13) d'Arminio A, et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 2004 ; 18 : 1811-1817.
PubMed
P.134 掲載の参考文献
1) Osame M, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986 ; 1 : 1031-1032.
PubMed
2) Abdullah HM, et al. Histopathologic differences between human T-lymphotropic virus type 1 (HTLV-1) -positive and HTLV-1-negative polymyositis. Clin Exp Neuroimmunol 2011 ; 2 : 12-17.
 
3) Matsuura E, et al. Inclusion body myositis associated with human T-lymphotropic virus-type I infection : Eleven patients from an endemic area in Japan. J Neuropathol Exp Neurol 2008 ; 67 : 41-49.
PubMed
4) Mochizuki M, et al. Uveitis associated with human T lymphotropic virus type I : Seroepidemiologic, clinical, and virologic studies. J Infect Dis 1992 ; 166 : 943-944.
PubMed
5) Nakagawa, M, et al. HTLV-I-associated myelopathy : Analysis of 213 patients based on clinical features and laboratory findings. J Neurovirol 1995 ; 1 : 50-61.
PubMed
6) 出雲周二ほか. HAMの新しい展開. 神経内科 2011 ; 75 : 369-373.
 
7) Osame M, et al. Blood transfusion and HTLV-I associated myelopathy. Lancet 1986 ; 2 : 104-105.
PubMed
8) Izumo S. Neuropathology of HTLV-1-associated myelopathy (HAM/TSP). Neuropathology 2010 ; 30 : 480-485.
PubMed
9) Matsuoka E, et al. Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy / tropical spastic paraparesis : Double staining of immunohistochemistry and polymerase chain reaction in situ hybridization. Acta Neuropathol 1998 ; 96 : 340-346.
PubMed
10) Nagai M, et al. Analysis of HTLV-I proviral load in 202 HAM / TSP patients and 243 asymptomatic HTLV-I carriers : High proviral load strongly predisposes to HAM / TSP. J Neurovirol 1998 ; 4 : 586-593.
PubMed
11) Nagai M, et al. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy / tropical spastic paraparesis : Correlation with HTLV-I provirus load. J Infect Dis 2001 ; 183 : 197-205.
 
12) Nozuma S, et al. Familial clusters of HTLV-1-associated myelopathy / tropical spastic paraparesis. PLoS One 2014 ; 9 : e86144.
PubMed
13) Vine AM, et al. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy / tropical spastic paraparesis. J Infect Dis 2002 ; 186 : 932-939.
PubMed
14) Sato T, et al. CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy / tropical spastic paraparesis. PLoS Negl Trop Dis 2013 ; 7 : e2479.
PubMed
15) Takenouchi N, et al. Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy / tropical spastic paraparesis. J Neurovirol 2003 ; 9 : 29-35.
PubMed
16) Izumo S, et al. Interferon-alpha is effective in HTLV-I-associated myelopathy : A multicenter, randomized, double-blind, controlled trial. Neurology 1996 ; 46 : 1016-1021.
PubMed
17) Iwanaga M, et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers : A nationwide prospective study in Japan. Blood 2010 ; 116 : 1211-1219.
PubMed
18) Osame M, et al. HTLV-I-associated myelopathy (HAM). Treatment trials, retrospective survey and clinical and laboratory findings. Hematol Rev 1990 ; 3 : 271-284.
 

III. 細菌感染症

P.148 掲載の参考文献
1) Kamei S, Takasu T. Nationwide survey of the annual prevalence of viral and other neurological infections in Japanese inpatients. Intern Med 2000 ; 39 : 894-900.
PubMed
2) 砂川慶介ほか. 本邦における1997年7月以降3年間の小児化膿性髄膜炎の動向. 感染症学雑誌 2001 ; 75 : 931-939.
 
3) 新庄正宜ほか. 本邦における小児細菌性髄膜炎の動向 (2009-2010). 感染症学雑誌 2012 ; 86 : 582-591.
 
4) Chiba N, et al. Rapid detection of eight causative pathogens for the diagnosis of bacterial meningitis by real-time PCR. J Infect Chemother 2009 ; 15 : 92-98.
PubMed
5) 日本産科婦人科学会, 日本産婦人科医会 (編・監). 産婦人科診療ガイドライン-産科編 2011. 東京 : 日本産科婦人科学会事務局 ; 2011. http://www.jsog.or.jp/activity/pdf/gl_sanka_2011.pdf
 
6) Morozumi M, et al. Associations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections. Epidemiol Infect 2014 ; 142 : 812-819.
PubMed
7) Ubukata K, et al. Longitudinal surveillance of Haemophilus influenzae isolates from pediatric patients with meningitis throughout Japan, 2000-2011. J Infect Chemother 2013 ; 19 : 34-41.
 
8) 厚生労働科学研究費補助金 新型インフルエンザ等新興・再興感染症研究事業. 重症型のレンサ球菌・肺炎球菌感染症に対するサーベイランスの構築と病因解析, その診断・治療に関する研究 (H22-新興-一般-013 / 研究代表 : 生方公子). http://strep.umin.jp/index.html
 
9) Thigpen MC, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011 ; 364 : 2016-2025.
PubMed
10) Hsu HE, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009 ; 360 : 244-256.
PubMed
11) Carpenter RR, Petersdorf RG. The clinical spectrum of bacterial meningitis. Am J Med 1962 ; 33 : 262-275.
PubMed
12) Begg N, et al. Consensus statement on diagnosis, investigation, treatment and prevention of acute bacterial meningitis in immunocompetent adults. British Infection Society Working Party. J Infect 1999 ; 39 : 1-15.
 
13) Flores-Cordero JM, et al. Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit : Clinical manifestations, management and prognostic factors. Intensive Care Med 2003 ; 29 : 1967-1973.
 
14) van de Beek D, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004 ; 351 : 1849-1859.
PubMed
15) Feldman WE. Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis. J Pediatr 1976 ; 88 (4 Pt 1) : 549-552.
 
16) Greenlee JE, Carroll KC. Cerebrospinal fluid in CNS infections. In : Scheld WM, et al (editors). Infections of the Central Nervous System, 2nd edition. Philadelphia : Lippincott-Raven ; 1996, pp.899-922.
 
17) Cherian T, et al. PCR-Enzyme immunoassay for detection of Streptococcus pneumoniae DNA in cerebrospinal fluid samples from patients with culture-negative meningitis. J Clin Microbiol 1998 ; 36 : 3605-3608.
PubMed
18) Thomson RB Jr, Bertram H. Laboratory diagnosis of central nervous system infections. Infect Dis Clin North Am 2001 ; 15 : 1047-1071.
PubMed
19) Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev 1992 ; 5 : 130-145.
PubMed
20) Henney JE. Quick test for pneumonia. JAMA 1999 ; 282 : 1218.
 
21) Genne D, et al. Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Binax NOW). Int J Infect Dis 2006 ; 10 : 124-128.
PubMed
22) Dubos F, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children : A European multicenter case cohort study. Arch Pediatr Adolesc Med 2008 ; 162 : 1157-1163.
PubMed
23) Stearman M, Southgate HJ. The use of cytokine and C-reactive protein measurements in cerebrospinal fluid during acute infective meningitis. Ann Clin Biochem 1994 ; 31 (Pt 3) : 255-261.
 
24) Genton B, Berger JP. Cerebrospinal fluid lactate in 78 cases of adult meningitis. Intensive Care Med 1990 ; 16 : 196-200.
PubMed
25) Lauwers S. Lactic-acid concentration in cerebrospinal fluid and differential diagnosis of meningitis. Lancet 1978 ; 2 (8081) : 163.
PubMed
26) Brook I, et al. Measurement of lactic acid in cerebrospinal fluid of patients with infections of the central nervous system. J Infect Dis 1978 ; 137 : 384-390.
PubMed
27) Mandal BK, et al. How useful is cerebrospinal fluid lactate estimation in differential diagnosis of meningitis? J Infect 1983 ; 6 : 231-237.
PubMed
28) Stahel PF, et al. Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis. Lancet 1997 ; 349 (9069) : 1886-1887.
PubMed
29) Linder A, et al. Heparin-binding protein : A diagnostic marker of acute bacterial meningitis. Crit Care Med 2011 ; 39 : 812-817.
PubMed
30) Holub M, et al. Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. Crit Care 2007 ; 11 : R41.
PubMed
31) Determann RM, et al. Soluble triggering receptor expressed on myeloid cells 1 : A biomarker for bacterial meningitis. Intensive Care Med 2006 ; 32 : 1243-1247.
PubMed
32) Tang RB, et al. Interleukin-1beta and tumor necrosis factor-alpha in cerebrospinal fluid of children with bacterial meningitis. Childs Nerv Syst 2001 ; 17 : 453-456.
PubMed
33) Hsieh CC, et al. Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis. Childs Nerv Syst 2009 ; 25 : 461-465.
PubMed
34) 高橋恵子ほか. <第54回日本神経学会学術大会一般演題> 院内感染による細菌性髄膜炎本邦成人例における起炎菌と転帰影響要因. 臨床神経学 2013 ; 53 : 1461.
 
35) Allen SJ, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE) : A randomised, double-blind, placebo- controlled, multicentre trial. Lancet 2013 ; 382 (9900) : 1249-1257.
PubMed
36) Proulx N, et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005 ; 98 : 291-298.
PubMed
37) de Gans J, et al. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002 ; 347 : 1549-1556.
PubMed
38) Molyneux EM, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi : A randomised controlled trial. Lancet 2002 ; 360 (9328) : 211-218.
PubMed
39) Scarborough M, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med 2007 ; 357 : 2441-2450.
PubMed
40) Peltola H, et al. Adjuvant glycerol and / or dexamethasone to improve the outcomes of childhood bacterial meningitis : A prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007 ; 45 : 1277-1286.
 
41) 石川晴美, 亀井聡. 細菌性髄膜炎の診療ガイドラインの改訂. 第55回日本神経学会学術大会プログラム・抄録集. 2014, 抄録 p.242.
 
P.156 掲載の参考文献
・ Moller-Hartman W, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002 ; 44 : 371-381.
 
・ Britt RH, Enzmann DR. Clinical stages of human brain abscesses on serial CT scans after contrast infusion. Computerized tomographic, neuropathological, and clinical correlations. J Neurosurg 1983 ; 59 (6) : 972-989.
PubMed
・ Working party of the British Society for antimicrobial chemotherapy. The rational use of antibiotics in the treatment of brain abscess. Br J Neurosurg 2000 ; 14 (6) : 525-530.
 
・ Stephanov S. Surgical treatment of brain abscess. Neurosurgery 1988 ; 22 (4) : 724-730.
PubMed
・ Muzumdar D, et al. Brain abscess : An over view. Int J Surg 2011 ; 9 (2) : 136-144.
 
・ Brouwer MC, et al. Clinical characteristics and outcome of brain abscess : Systematic review and meta-analysis. Neurology 2014 ; 82 (9) : 806-813.
PubMed
・ 島津智一. 脳膿瘍. Clinical Neuroscience 2005 ; 23 (5) : 756-759.
 
・ Mamelak JM, et al. Nocardial brain abscess : Treatment strategies and factors influencing outcome. Neurosurgery 1994 ; 35 : 622-631.
 
・ Singh SM, et al. Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone. CMAJ 2004 ; 171 (9) : 1063-1064.
PubMed
・ Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004 ; 363 : 1965-1976.
PubMed
・ 都築伸介. 硬膜下膿瘍. Clinical Neuroscience 2005 ; 23 (5) : 764.
 
・ Feuerman T, et al. Craniotomy improves outcome in subdural empyema. Surg Neurol 1989 ; 32 (2) : 105-110.
PubMed
・ Pradilla G, et al. Epidural abscesses of the CNS. Lancet Neurol 2009 ; 8 (3) : 292-300.
PubMed
P.165 掲載の参考文献
1) Kent SJ, et al. Tuberculous meningitis : A 30-year review. Clin Infect Dis 1993 ; 17 : 987-994.
PubMed
2) Marais S, et al. Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. PLoS One 2011 ; 6 : e20077.
 
3) Kumar R, et al. A diagnostic rule for tuberculous meningitis. Arch Dis Child 1999 ; 81 : 221-224.
 
4) Thwaites GE, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004 ; 351 : 1741-1751.
PubMed
5) Green JA, et al. Dexamethasone, cerebrospinal fluid matrix metalloprotease concentrations and clinical outcomes in tuberculous meningitis. PLoS One 2009 ; 4 : e7277.
PubMed
6) Thwaites GE, et al. Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother 2011 ; 55 : 3244-3253.
PubMed
・ Thwaites G. The Diagnosis and Pathophysiology of Tuberculous Meningitis. Saarbrucken, Deutschland : VDM verlag ; 2009.
 
・ Leonard JM. Central nervous system tuberculosis. UpToDate. http://www.uptodate.com (last updated Nov 8, 2013)
 
・ Thwaites GE, Tran TH. Tuberculous meningitis : Many questions, too few answers. Lancet Neurol 2005 ; 4 : 160-170.
PubMed
・ 荒木邦彦, 福武敏夫. 結核性髄膜炎. Clinical Neuroscience 2010 ; 28 : 300-302.
 
・ Thwaites GE, et al. Tuberculous meningitis : More questions, still too few answers. Lancet Neurol 2013 ; 12 : 999-1010.
PubMed
P.170 掲載の参考文献
1) 岩田誠. ハンセン病における末梢神経障害. 大谷藤郎 (監修), 牧野正直ほか (編), 総説現代ハンセン病医学. 東京 : 東海大学出版会 ; 2007, pp.228-240.
 
2) Sabin TD, Swift TR. Leprosy. In : Dyck PJ, et al (editors). Diseases of the Peripheral Nervous System. Philadelphia : Saunders ; 1975, pp.1166-1198.
 
3) Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966 ; 34 : 255-273.
PubMed
4) 岩田誠. 神経症候学を学ぶ人のために. 東京 : 医学書院 ; 1994, pp.93-94, 111, 208-209, 285-286.
 
5) 尾崎元昭. 病型分類. 大谷藤郎 (監修), 牧野正直ほか (編), 総説現代ハンセン病医学. 東京 : 東海大学出版会 ; 2007, pp.178-203.
 
6) McDougall AC, Yuasa Y. A New Atlas of Leprosy. Tokyo : Sasakawa Memorial Health Foundation ; 2001, pp.1-76.
 
・ 大谷藤郎 (監修), 牧野正直ほか (編), 総説現代ハンセン病医学. 東京 : 東海大学出版会 ; 2007.
 
P.175 掲載の参考文献
1) Tamura A, et al. Classification of Rickettsia tsutsugamushi in a new genus, Orientia gen. nov. as Orientia tsutsugamushi comb. nov. Int J Syst Bacteriol 1995 ; 45 : 589-591.
 
2) 田原研司, 山本正悟. つつが虫病 多種多彩な疫学. SADI組織委員会 (編), ダニと新興再興感染症. 東京 : 全国農村教育協会 ; 2007, pp.151-164.
 
3) Moron CG, et al. Identification of the target cells of Orientia tsutsugamushi in human cases of scrub typhus. Mod Pathol 2001 ; 14 : 752-759.
PubMed
4) Furuya Y, et al. Serotype-specific amplification of Rickettsia tsutsugamushi DNA by nested polymerase chain reaction. J Clin Microbiol 1993 ; 31 : 1637-1640.
PubMed
5) Allen AC, Spitz S. A comparative study of the pathology of scrub typhus (tsutsugamushi disease) and other rickettsial diseases. Am J Pathol 1945 ; 21 : 603-681.
 
6) Silpapojakul K, et al. Rickettsial meningitis and encephalitis. Arch Intern Med 1991 ; 151 : 1753-1757.
PubMed
7) Mahajan SK, et al. Scrub typhus involving central nervous system, India, 2004-2006. Emerg Infect Dis 2010 ; 16 : 1641-1643.
PubMed
8) Pai H, et al. Central nervous system involvement in patients with scrub typhus. Clin Infect Dis 1997 ; 24 : 436-440.
PubMed
9) 今野卓哉, 藤田信也. ツツガムシと神経系. 神経内科 2012 ; 77 : 233-237.
 
10) Kim DE, et al. Scrub typhus encephalomyelitis with prominent focal neurologic signs. Arch Neurol 2000 ; 57 : 1770-1772.
PubMed
11) 荒井元美ほか. 三叉神経痛様の疼痛を主症状としたツツガムシ病. 臨床神経学 2007 ; 47 : 362-364.
 
12) Hayakawa K, et al. A case of scrub typhus with acalculous cholecystitis, aseptic meningitis and mononeuritis multiplex. J Med Microbiol 2012 ; 61 : 291-294.
 
13) 馬原文彦. 発疹と高熱を主徴としWeii-Felix反応 (OX2) 陽性を示した3症例について. 阿南医報 1984 ; 68 : 4-7.
 
14) 馬原文彦. 日本紅斑熱の治療-重症例, 死亡例の検討と併用療法の有用性. 病原微生物検出情報 (IASR) 2006 ; 27 : 37-38.
 
・ 多村憲. 恙虫病病原体Orientia tsutsugamushiの微生物学. 日本細菌学雑誌 1999 ; 54 : 815-832.
Medical*Online
・ 宮村定男. 恙蟲病研究夜話, 増補第2版. 新潟 : 考古堂書店 ; 1988.
 
P.180 掲載の参考文献
1) Yesnick L. Central nervous system complications of primary atypical pneumonia. AMA Arch Intern Med 1956 ; 97 : 93-98.
PubMed
2) Lerer RJ, Kalavsky SM. Central nervous system disease associated with Mycoplasma pneumoniae infection : Report of five cases and review of the literature. Pediatrics 1973 ; 52 : 658-668.
PubMed
3) Ponka A. Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection. Scand J Infect Dis 1980 ; 12 : 175-184.
PubMed
4) 坂田宏ほか. Mycoplasma genitalium による脳幹脳炎の1例. 感染症誌 1993 ; 67 : 500-504.
 
5) Baum SG. Mycoplasma hominis, Mycoplasma genitalium, and Ureaplasma urealyticum infections. UpToDate version 9.0.
 
6) Narita M. Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection. Pediatr Neurol 2009 ; 41 : 159-166.
PubMed
7) Kusunoki S, et al. Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection. Muscle Nerve 1995 ; 18 : 409-413.
 
8) Samukawa M, et al. Refractory acute disseminated encephalomyelitis with anti-galactocerebroside antibody. Neurosci Res 2012 ; 74 : 284-289.
PubMed
9) Narita M, et al. Analysis of mycoplasmal central nervous system involvement by polymerase chain reaction. Pediatr Infect Dis J 1995 ; 14 : 236-237.
PubMed
10) 成田光生ほか. マイコプラズマ感染に伴った急性小脳失調症の1例と文献的考察. 臨床小児医学 2011 ; 59 : 36-39.
 
11) 奥村恵子ほか. マイコプラズマ感染後に急性両側線条体壊死を呈した1例. 脳と発達 2011 ; 43 : 471-475.
Medical*Online
12) 楠進. Guillain-Barre症候群 (GBS) とFisher症候群. 楠進 (編), 免疫性神経疾患ハンドブック. 東京 : 南江堂 ; 2013, pp.127-145.
 
13) Ang CW, et al. Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barre syndrome. J Neuroimmunol 2002 ; 130 : 179-183.
PubMed
14) Hao Q, et al. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections. J Neuroimmunol 1998 ; 81 : 116-126.
PubMed
15) Saida T, et al. Experimental allergic neuritis induced by sensitization with galactocerebroside. Science 1979 ; 204 : 1103-1106.
 
16) Kusunoki S, et al. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection : Evidence of molecular mimicry. Neurology 2001 ; 57 : 736-738.
 
17) 寒川真, 楠進. 感染性疾患マイコプラズマ感染症. 別冊日本臨牀, 新領域別症候群シリーズ No.26, 神経症候群 (第2版) I. 大阪 : 日本臨牀社 ; 2013, pp.838-842.
 
18) 角谷真人ほか. 抗ガラクトセレブロシド抗体陽性のマイコプラズマ感染後Guillain-Barre症候群の1例. 神経内科 2010 ; 72 : 519-523.
 
19) Susuki K, et al. Acute motor axonal neuropathy after Mycoplasma infection : Evidence of molecular mimicry. Neurology 2004 ; 62 : 949-956.
PubMed
20) Samukawa M, et al. Clinical features in Guillain-Barre syndrome with anti-Gal-C antibody. J Neurol Sci 2014 ; 337 : 55-60.
 
P.187 掲載の参考文献
1) 感染症疫学センター-国立感染症研究所. http://www.nih.go.jp/niid/ja/from-idsc.html
 
2) Centers for Disease Control and Prevention (CDC). Botulism from home-canned bamboo shoots --Nan Province, Thailand, March 2006. MMWR Morb Mortal Wkly Rep 2006 ; 55 : 389-392.
PubMed
3) Greenfield RA, et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci 2002 ; 323 : 326-340.
PubMed
4) Cherington M. Clinical spectrum of botulism. Muscle Nerve 1998 ; 21 : 701-710.
PubMed
5) Maselli RA, Bakshi N. AAEM case report 16. Botulism. American Association of Electrodiagnostic Medicine. Muscle Nerve 2000 ; 23 : 1137-1144.
 
6) Passaro DJ, et al. Wound botulism associated with black tar heroin among injecting drug users. JAMA 1998 ; 279 : 859-863.
PubMed
7) Chia JK, et al. Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum. N Engl J Med 1986 ; 315 : 239-241.
 
8) Bakheit AM, et al. Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A : A report of two cases. J Neurol Neurosurg Psychiatry 1997 ; 62 : 198.
 
9) Montecucco C, Schiavo G. Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 1994 ; 13 : 1-8.
PubMed
10) Sollner T, et al. SNAP receptors implicated in vesicle targeting and fusion. Nature 1993 ; 362 : 318-324.
PubMed
11) Shapiro BE, et al. Adult botulism. Muscle Nerve 1997 ; 20 : 100-102.
PubMed
12) Tacket CO, et al. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism. Am J Med 1984 ; 76 : 794-798.
PubMed
13) Puggiari M, Cherington M. Botulism and guanidine. Ten years later. JAMA 1978 ; 240 : 2276-2277.
PubMed
14) Bleck TP. Clinical aspect of tetanus. In : Simpson LL (editor). Botulinum neurotoxin and tetanus toxin. New York : Academic Press ; 1989, pp.379-398.
 
15) Farrar JJ, et al. Tetanus. J Neurol Neurosurg Psychiatry 2000 ; 69 : 292-301.
PubMed
16) Schwab ME, Thoenen H. Electron microscopic evidence for a transsynaptic migration of tetanus toxin in spinal cord motoneurons : An autoradiographic and morphometric study. Brain Res 1976 ; 105 : 213-217.
PubMed
17) Tarlov IM, et al. Neuronal pathology in experimental local tetanus. Clinical implications. Neurology 1973 ; 23 : 580-591.
PubMed
18) Auger RG. AAEM minimonograph #44 : Disease associated with excess motor unit activity. Muscle Nerve 1994 ; 17 : 1250-1263.
PubMed
19) Khuraibet AJ, et al. A case of neonatal tetanus with characteristic neurophysiological findings. Muscle Nerve 1998 ; 21 : 971-972.
PubMed
20) Ahmadsyah I, Salim A. Treatment of tetanus : An open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J (Clin Res Ed) 1985 ; 291 : 648-650.
PubMed
P.193 掲載の参考文献
1) Fenollar F, et al. Whipple's disease. N Engl J Med 2007 ; 356 : 55-66.
PubMed
2) Black-Schaffer B. The tinctoral demonstration of a glycoprotein in Whipple's disease. Proc Soc Exp Biol Med 1949 ; 72 : 225-227.
PubMed
3) Yardley JH, Hendrix TR. Combined electron and light microscopy in Whipple's disease. Demonstration of "bacillary bodies" in the intestine. Bull Johns Hopkins Hosp 1961 ; 109 : 80-98.
PubMed
4) Relman DA, et al. Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992 ; 327 : 293-301.
PubMed
5) Raoult D, et al. Cultivation of the bacillus of Whipple's disease. N Engl J Med 2000 ; 342 : 620-625.
PubMed
6) Marth T, Raoult D. Whipple's disease. Lancet 2003 ; 361 : 239-246.
PubMed
7) Mahnel R, et al. Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol 2005 ; 100 : 1167-1173.
PubMed
8) Yogi T, et al. Whipple's disease : The first Japanese case diagnosed by electron microscopy and polymerase chain reaction. Intern Med 2004 ; 43 : 566-570.
PubMed
9) 大久保智恵ほか. 抗菌化学療法が奏功したWhipple病の1例. 日本内科学会雑誌 2009 ; 98 : 2598-2600.
 
10) Uryu K, et al. Central nervous system relapse of Whipple's disease. Intern Med 2012 ; 51 : 2045-2050.
PubMed
11) Yajima N, et al. Whipple disease diagnosed with PCR using formalin-fixed paraffin-embedded specimens of the intestinal mucosa. Intern Med 2013 ; 52 : 219-222.
PubMed
12) 渡邉大輔ほか. 感染性心内膜炎と髄膜炎を合併したWhipple病の1例. 日本消化器病学会雑誌 2013 ; 110 : 998-1006.
Medical*Online
13) Canoso JJ, et al. Whipple's disease and ankylosing spondylitis simultaneous occurrence in HLA-B27 positive male. J Rheumatol 1978 ; 5 : 79-84.
 
14) Kremer S, et al. Diffuse lesions in the CNS revealed by MR imaging in a case of Whipple disease. AJNR Am J Neuroradiol 2001 ; 22 : 493-495.
 
15) Donmez FY, et al. MRI of recurrent isolated cerebral Whipple's disease. Diagn Interv Radiol 2010 ; 16 : 112-115.
PubMed
16) Street S, et al. Tropheryma whippelii DNA in saliva of healthy people. Lancet 1999 ; 354 : 1178-1179.
PubMed
17) Schneider T, et al. Whipple's disease : New aspects of pathogenesis and treatment. Lancet Infect Dis 2008 ; 8 : 179-190.
PubMed
18) Costello DJ, et al. Case records of the Massachusetts General Hospital. Case 1-2009. A 57-year-old man with progressive cognitive decline. N Engl J Med 2009 ; 360 : 171-181.
PubMed
P.199 掲載の参考文献
1) 国立感染症研究所. ブルセラ症検査マニュアル. http://www.nih.go.jp/niid/images/lab-manual/brucellosis_2012.pdf
 
2) Pappas G, et al. The new global map of human brucellosis. Lancet Infect Dis 2006 ; 6 : 91-99.
PubMed
3) ブルセラ症 1999年4月～2012年3月. IASR 2012 ; 33 : 183-185.
 
4) 矢野 (五味) 晴美ほか. ブルセラ感染症 (ブルセラ症). 別冊日本臨牀, 新領域別症候群シリーズ No.24, 感染症症候群 (第2版) 上. 大阪 : 日本臨牀社 ; 2013, pp.158-162.
 
5) Center for disease control and prevention. Bioterrorism agents / diseases. http://emergency.cdc.gov/agent/agentlist-category.asp
 
6) Gul HC, et al. Overview of neurobrucellosis : A pooled analysis of 187 cases. Int J Infect Dis 2009 ; 13 : e339-e343.
PubMed
7) Guven T, et al. Neurobrucellosis : Clinical and diagnostic features. Clin Infect Dis 2013 ; 56 : 1407-1412.
PubMed
8) 小泉信夫ほか. レプトスピラ感染症 (レプトスピラ症, ワイル病). 別冊日本臨牀, 新領域別症候群シリーズ No.24, 感染症症候群 (第2版) 上. 大阪 : 日本臨牀社 ; 2013, pp.257-260.
 
9) 後藤正彦ほか. 長崎縣下の秋季レプトスピラ病分布調査補遺. 長崎大学風土病研究所業績 1. 1952, pp.235-240.
 
10) Mathew T, et al. Neuroleptospirosis-revisited : Experience from a tertiary care neurological centre from south india. Indian J Med Res 2006 ; 124 : 155-162.
PubMed
11) 国立感染症研究所. レプトスピラ症病原体検査マニュアル. http://www.nih.go.jp/niid/images/lab-manual/leptospirosis_2011.pdf
 
12) Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev 2012 ; 2 : CD008264.
PubMed
13) 小橋吉博ほか. 放線菌症. 別冊日本臨牀, 新領域別症候群シリーズ No.24, 感染症症候群 (第2版) 上. 大阪 : 日本臨牀社 ; 2013, pp.261-264.
 
14) Wong VK, et al. Actinomycosis. BMJ 2011 ; 343 : d6099.
PubMed
15) Smego RA Jr. Actinomycosis of the central nervous system. Rev Infect Dis 1987 ; 9 : 855-865.
PubMed
16) 渡邉哲ほか. 肺ノカルジア症. 別冊日本臨牀, 新領域別症候群シリーズ No.24, 感染症症候群 (第2版) 上. 大阪 : 日本臨牀社 ; 2013, pp.265-267.
 
17) Wilson JW. Nocardiosis : Updates and clinical overview. Mayo Clin Proc 2012 ; 87 : 403-407.
PubMed
18) Anagnostou T, et al. Nocardiosis of the central nervous system : Experience from a general hospital and review of 84 cases from the literature. Medicine (Baltimore) 2014 ; 93 : 19-32.
 
・ Doganay GD, Doganay M. Brucella as a potential agent of bioterrorism. Recent Pat Antiinfect Drug Discov 2013 ; 8 : 27-33.
PubMed

IV. スピロヘータ感染症

P.206 掲載の参考文献
1) Hashimoto S, et al. Epidemics of vector-borne diseases observed in infectious disease surveillance in Japan, 2000-2005. J Epidemiol 2007 ; 17 (Suppl) : S48-S55.
PubMed
2) 橋本喜夫. ボレリア感染症 (ライム病). 玉置邦彦 (総編), 最新皮膚科学大系14 巻, 細菌・真菌性疾患. 東京 : 中山書店 ; 2003, pp.313-316.
 
3) Halperin J, et al. Lyme neuroborreliosis. Peripheral nervous system manifestations. Brain 1990 ; 113 (Pt 4) : 1207-1221.
 
4) Stanek G, Strle F. Lyme disease : European perspective. Infect Dis Clin North Am 2008 ; 22 : 327-339, vii.
PubMed
5) Halperin JJ, Golightly M. Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group. Neurology 1992 ; 42 : 1268-1270.
 
6) 保前英希ほか. Bell 麻痺患者における血清抗Borrelia burgdorferi抗体の検討. Facial Nerve Research Japan 1993 ; 13 : 71-74.
Medical*Online
7) 古田康ほか. 末梢性顔面神経麻痺症例における抗ボレリア抗体の検索. Facial Nerve Research Japan 2001 ; 21 : 51-53.
Medical*Online
8) Halperin JJ. Prolonged Lyme disease treatment : Enough is enough. Neurology 2008 ; 70 : 986-987.
PubMed
9) 秋本幸子, 佐々木秀直. ライム病 (神経ボレリア症). Clinical Neuroscience 2010 ; 28 : 314-315.
 
10) Nau R, et al. Lyme disease--Current state of knowledge. Dtsch Arztebl Int 2009 ; 106 : 72-81 ; quiz 82, I.
PubMed
11) 川端寛樹. ライム病とは. 国立感染症研究所 HP <IDWR感染症の話>. http://www.nih.go.jp/niid/ja/encycropedia/392-encyclopedia/524-lyme.html
 
12) Lakos A. CSF findings in Lyme meningitis. J Infect 1992 ; 25 : 155-161.
PubMed
13) Schmidt C, et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011 ; 76 : 1051-1058.
 
14) Halperin JJ, et al. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology 1991 ; 41 : 1571-1582.
PubMed
15) Nocton JJ, et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. J Infect Dis 1996 ; 174 : 623-627.
PubMed
16) Halperin JJ. Nervous system Lyme disease. Infect Dis Clin North Am 2008 ; 22 : 261-274, vi.
PubMed
17) Wormser GP, et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis : Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2006 ; 43 : 1089-1134.
 
18) 河野祐治ほか. 高度の嚥下障害を呈したボレリア脳幹脳炎の1例. 臨床神経学 2010 ; 50 : 265-267.
 
19) 高堂裕平ほか. 抗菌薬と副腎皮質ステロイド薬の併用が有効であった神経ボレリア症の1例. 臨床神経学 2012 ; 52 : 411-415.
 
P.215 掲載の参考文献
1) Tramont EC. Treponema pallidum (Syphilis). In : Mandell GL, et al (editors). Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th edition. Philadelphia : Elsevier ; 2010, pp.3035-3058.
 
2) Golden MR, et al. Update on syphilis : Resurgence of an old problem. JAMA 2003 ; 290 : 1510-1514.
PubMed
3) Lukehart SA. Syphilis. In : Fauci AS, et al (editors). Harrison's Principles of Internal Medicine, 17th edition. New York : McGraw-Hill ; 2008, pp.1038-1046.
 
4) Ropper AH, Samuels MA. Adams and Victor's Principles of Neurology, 9th edtion. New York : McGraw-Hill ; 2009.
 
5) Marra CM. Neurosyphilis. http://www.uptodate.com/contents/neurosyphilis
 
6) Fujimoto H, et al. Neurosyphilis showing transient global amnesia-like attacks and magnetic resonance imaging abnormalities mainly in the limbic system. Intern Med 2001 ; 40 : 439-442.
PubMed
7) Scheid R, et al. Neurosyphilis and paraneoplastic limbic encephalitis : Important differential diagnoses. J Neurol 2005 ; 252 : 1129-1132.
PubMed
8) Hama K, et al. Neurosyphilis with mesiotemporal magnetic resonance imaging abnormalities. Intern Med 2008 ; 47 : 1813-1817.
PubMed
9) Bash S, et al. Mesiotemporal T2-weighted hyperintensity : Neurosyphilis mimicking herpes encephalitis. AJNR Am J Neuroradiol 2001 ; 22 : 314-316.
PubMed
10) GUrses C, et al. Neurosyphilis presenting with status epilepticus. Epileptic Disord 2007 ; 9 : 51-56.
PubMed
11) Sinha S, et al. Symptomatic seizures in neurosyphilis : An experience from a university hospital in south India. Seizure 2008 ; 17 : 711-716.
PubMed
12) Centers for Disease Control Prevention, et al. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2006 ; 55 : 1-94.
 
13) 池口邦彦. 神経梅毒. Clinical Neuroscience 2010 ; 28 : 310-313.
 
14) Kodama K, et al. Relationship between MRI findings and prognosis for patients with general paresis. J Neuropsychiatry Clin Neurosci 2000 ; 12 : 246-250.
PubMed

V. 真菌症

P.221 掲載の参考文献
1) Weenink HR, Bruyn GW. Cryptococcosis of the nervous system. In : Vinken PJ, et al (editors). Handbook of Clinical Neurology, Vol 35. Amsterdam : North-Holland Publishing Company ; 1978, pp.459-502.
 
2) 堀内一宏ほか. 脳室内抗真菌薬投与が奏功したCryptococcus gattii による脳および肺クリプトコッカス症の1例. 臨床神経学 2012 ; 52 : 166-171.
 
3) Tien RD, et al. Intracranial cryptococcosis in immunocompromised patients : CT and MR findings in 29 cases. AJNR Am J Neuroradiol 1991 ; 12 : 283-289.
 
4) Saag MS, et al. Practice guidelines for the management of cryptococcal disease. Infectious Disorder Society of America. Clin Infect Dis 2000 ; 30 : 710-718.
PubMed
5) 深在性真菌症のガイドライン作成委員会 (編). 深在性真菌症の診断・治療ガイドライン 2007. 東京 : 協和企画 ; 2007.
 
6) 深在性真菌症のガイドライン作成委員会 (編). 深在性真菌症の診断・治療ガイドライン 2014. 東京 : 協和企画 ; 2014.
 
P.225 掲載の参考文献
1) Wisplinghoff H, et al. Nosocomial bloodstream infections in US hospitals : Analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004 ; 39 : 309-317.
PubMed
2) Parker JC Jr, et al. Human cerebral candidosis--A postmortem evaluation of 19 patients. Human Pathol 1981 ; 12 : 23-28.
 
3) Pendlebury WW, et al. Multiple microabscesses in the central nervous system : A clinicopathologic study. J Neuropathol Exp Neurol 1989 ; 48 : 290-300.
PubMed
4) Sanchez-Portocarrero J, et al. The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis 2000 ; 37 : 169-179.
PubMed
5) Nguyen MH, Yu VL. Meningitis caused by Candida species : An emerging problem in neurosurgical patients. Clin Infect Dis 1995 ; 21 : 323-327.
PubMed
6) Sanchez-Portocarrero J, et al. Candida cerebrospinal fluid shunt infection : Report of two new cases and review of the literature. Diagn Microbiol Infect Dis 1994 ; 20 : 33-40.
PubMed
7) Voice RA, et al. Chronic candidal meningitis : An uncommon manifestation of candidiasis. Clin Infect Dis 1994 ; 19 : 60-66.
 
8) Geers TA, Gordon SM. Clinical significance of Candida species isolated from cerebrospinal fluid following neurosurgery. Clin Infect Dis 1999 ; 28 : 1139-1147.
PubMed
9) Casado JL, et al. Candidal meningitis in HIV infected patients : Analysis of 14 cases. Clin Infect Dis 1997 ; 25 : 673-676.
PubMed
10) Smego RA Jr, et al. Combined therapy with amphotericin B and 5-fluorocytosine for Candida meningitis. Rev Infect Dis 1984 ; 6 : 791-801.
PubMed
11) Karen L Roos. 湯浅龍彦 (訳). 髄膜炎の100章. 新潟 : 西村書店 ; 2003, pp.144-159.
 
12) Nakayama H, et al. Histopathological study of candidal infection in the central nervous system. Nippon Ishinkin Gakkai Zasshi 2010 ; 51 : 31-45.
 
13) Lutsar I, et al. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis 2003 ; 37 : 728-732.
PubMed
P.232 掲載の参考文献
1) Kourkoumpetis TK, et al. Central nervous system aspergillosis : A series of 14 cases from a general hospital and review of 123 cases from the literature. Medicine (Baltimore) 2012 ; 91 : 328-336.
PubMed
2) Walia U, et al. Cerebro-rhino orbital mucormycosis : An update. J Infect Public Health 2012 ; 5 : 116-126.
 
3) 吉田耕一郎. 侵襲性アスペルギルス症の診断. Med Mycol J 2013 ; 54 : 323-327.
 
4) Hibbett DS, et al. A higher-level phylogenetic classification of the Fungi. Mycol Res 2007 ; 111 : 509-547.
PubMed
5) Klont RR, et al. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 2004 ; 39 : 1467-1474.
PubMed
6) Reinwald M, et al. Diagnostic performance of an aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS ONE 2013 ; 8 (2) : e56706.
PubMed
7) 森健ほか. Zygomycosis (接合菌症). Med Mycol J 2011 ; 52 : 283-289.
 
8) 深在性真菌症のガイドライン作成委員会 (編). 深在性真菌症の診断・治療ガイドライン 2014. 東京 : 協和企画 ; 2014.
 
9) Walsh TJ, et al. Treatment of aspergillosis : Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008 ; 46 : 327-360.
 
10) Rogers TR. Treatment of zygomycosis : Current and new options. J Antimicrob Chemother 2008 ; 61 (Suppl 1) : 35-40.
 
11) Enoch DA, et al. Posaconazole for the treatment of mucormycosis. Int J Antimicrob Agents 2011 ; 38 : 465-473.
PubMed
12) Spellberg B, et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study : A randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 2012 ; 67 : 715-722.
 
・ 山口英世. 病原真菌と真菌症, 改訂4版. 東京 : 南山堂 : 2007.
 
P.236 掲載の参考文献
1) Kamei K, et al. The trend of imported mycoses in Japan. J Infect Chemother 2003 ; 9 (1) : 16-20.
PubMed
2) 亀井克彦. 海外旅行と真菌症-その注意点. 医学のあゆみ 2008 ; 225 (3) : 232-236.
Medical*Online
3) Wheat LJ. Histoplasmosis : A review for clinicians from non-endemic areas. Mycoses 2006 ; 49 : 274-282.
PubMed
4) Wheat LJ. Histoplasmosis. Experience during outbreaks in Indianapolis and review of literature. Medicine (Baltimore) 1997 ; 76 (5) : 339-354.
 
5) Wheat LJ, et al. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005 ; 40 (6) : 844-852.
PubMed
6) Wheat LJ, et al. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore) 1980 ; 69 (4) : 244-260.
 
7) Li RK, et al. In vitro activities of voriconazole, itraconazol, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother 2000 ; 44 (6) : 1734-1736.
PubMed
8) Ghannoum MA, Kuhn DM. Voliconazol--better chanses for patients with invasive mycoses. Eur J Med Res 2002 ; 7 (5) : 242-256.
 
9) Enarson DA, et al. Central nervous system histoplasmosis with obstructive hydrocephalus. Am J Med 1978 ; 64 : 895-896.
PubMed
10) Tiraboschi I, et al. Chronic Histoplasma capsulatum infection of the central nervous system successfully treated with fluconazole. Eur Neurol 1992 ; 32 : 70-73.
PubMed
11) Ploufee JF, Fass RJ. Histoplasma meningitis : Diagnostic value of cerebrospinal fluid serology. Ann Intern Med 1980 ; 92 (2 Pt 1) ; 189-191.
 

VI. 原虫・寄生虫感染症

P.244 掲載の参考文献
1) Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004 ; 363 : 1965-1976.
PubMed
2) Sakikawa M, et al. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4.466 pregnant women in Japan. Clin Vaccine Immunol 2012 ; 19 : 365-367.
 
3) Lopez R, et al. Presence of antibodies against Toxoplasma gondii in adolescents from the African continent. Rev Latinoam Microbiol 1992 ; 34 : 49-52.
PubMed
4) Cavalcante GT, et al. Seroprevalence of Toxoplasma gondii antibodies in humans from rural Western Amazon, Brazil. J Parasitol 2006 ; 92 : 647-649.
 
5) 中村 (内山) ふくみ, 大西健児. トキソプラズマ症. 化学療法の領域 2008 ; 4 (9) : 1328-1333.
 
6) Habek M, et al. Unusual cause of dementia in an immunocompetent host : Toxoplasmic encephalitis. Neurol Sci 2009 ; 30 : 45-49.
 
7) Cohen BA. Neurologic manifestations of toxoplasmosis in AIDS. Semin Neurol 1999 ; 19 : 201-211.
 
8) 藤井明弘, 栗山勝. トキソプラズマ脳炎. Clinical Neuroscience 2010 ; 28 (3) : 316-318.
 
9) Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med 1992 ; 327 : 1643-1648.
PubMed
10) Collazos J. Opportunistic infections of the CNS in patients with AIDS : Diagnosis and management. CNS Drugs 2003 ; 17 : 869-887.
PubMed
11) Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis 1992 ; 15 : 211-222.
PubMed
12) 矢野明彦ほか. 先天性トキソプラズマ症. 矢野明彦 (編著). 日本におけるトキソプラズマ症. 福岡 : 九州大学出版会 ; 2007, pp.25-67.
 
13) Luft BJ, et al. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. JAMA 1984 ; 252 : 913-917.
PubMed
14) Kobayashi T, et al. AIDS related Toxoplasmic Encephalitis in the Era of Antiretroviral Therapy in Japan (H-223). 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, USA ; 2012.
 
15) 岸田修二. HAART導入下でのHIVの神経系日和見感染. 化学療法の領域 2004 ; 20 (10) : 46-54.
 
16) 浅井隆志. トキソプラズマ脳炎のPCR検査法. 臨床神経学 2013 ; 53 : 1194-1195.
 
17) Lau YL, et al. Specific, sensitive, and rapid diagnosis of active toxoplasmosis by a loop-mediated isothermal amplification method using blood samples from patients. J Clin Microbiol 2010 ; 48 : 3698-3702.
PubMed
18) 岸田修二. トキソプラズマ症. 別冊日本臨牀. 新領域別症候群シリーズ No.26, 神経症候群 I. 大阪 : 日本臨牀社 ; 1999, pp.650-658.
 
19) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992 ; 41 : 1-19.
PubMed
20) 小林泰一郎. トキソプラズマ症. 別冊日本臨牀, 新領域別症候群シリーズ No.26, 神経症候群 (第2版) I. 大阪 : 日本臨牀社 ; 2013, pp.883-887.
 
P.250 掲載の参考文献
1) WHO. World malaria report 2013. http://www.who.int/malaria/publications/world_malaria_report_2013/en/
 
2) 国立感染症研究所感染症情報センター. http://idsc.nih.go.jp/disease/malaria/2010week38/sokuhou01.gif (2014年3月8日現在)
 
3) Nicholas JW. Malaria. In : Jeremy F, et al. Manson's Tropical Diseases, 23rd edition. Saunders ; 2014, pp.532-600.
 
4) WHO. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000 ; 94 (Suppl 1) : S1-90.
 
5) Taylor TE, et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 2004 ; 10 : 143-145.
PubMed
6) Idro R, et al. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005 ; 4 : 827-840.
PubMed
7) Newton CR, et al. Pathophysiology of fatal falciparum malaria in African children. Am J Trop Med Hyg 1998 ; 58 : 673-683.
PubMed
8) Lewallen S, et al. Clinical-histopathological correlation of the abnormal retinal vessels in cerebral malaria. Arch Ophthalmol 2000 ; 118 : 924-928.
PubMed
9) Beare NA, et al. Prognostic significance and course of retinopathy in children with severe malaria. Arch Ophthalmol 2004 ; 122 : 1141-1147.
PubMed
10) Clark IA, Alleva LM. Is human maralial coma caused, or merely deepened, by sequestration? Trends Parasitol 2009 ; 25 : 314-318.
PubMed
11) Grau GE, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989 ; 15 : 1586-1591.
 
12) Adams S, et al. Breaking down the blood-brain-barrier : Signaling a path to cerebral malaria? Trends Parasitol 2002 ; 18 : 360-366.
PubMed
13) Newton CR, et al. Brain swelling and ischemia in Kenyans with cerebral malaria. Arch Dis Child 1994 ; 70 : 281-287.
PubMed
14) Mturi N, et al. Cerebospinal fluid studies in Kenyan children with severe falciparum malaria. Open Trop Med J 2010 ; 1 : 56-62.
 
15) WHO. Guidelines for the treatment of malaria, 2nd edition. Geneva : WHO ; 2010.
 
16) Dondorp A, et al ; South East Asias Quinine Artesunate Malaria Trial (SEQUAMAT) group. Artesnate versus quinine for treatment of severe falciparum malaria : A randomized trial. Lancet 2005 ; 366 : 717-725.
 
P.256 掲載の参考文献
1) 吉田幸雄, 有薗直樹. 図説人体寄生虫学, 改訂第8版. 東京 : 南山堂 ; 2011, pp.26-31.
 
2) Culbertson CG. Pathogenic Acanthamoeba (Hartmanella). Am J Clin Pathol 1961 ; 35 : 195-202.
PubMed
3) Fowler M, Carter RF. Acute pyogenic meningitis probably due to Acanthamoeba sp. : A preliminary report. Br Med J 1965 ; 2 : 740-742.
PubMed
4) Visvesvara GS, et al. Balamuthia mandrillaris, N. G., N. Sp., agent of amebic meningoencephalitis in humans and other animals. J Eukaryot Microbiol 1993 ; 40 : 504-514.
 
5) Gelman BB, et al. Amoebic encephalitis due to Sappinia diploidea. JAMA 2001 ; 285 : 2450-2451.
PubMed
6) Hara T, et al. Free living amebae isolated from an acutely progressive meningoencephalitis patient. Parasitol Int 1997 ; 46 (Suppl) : 149.
 
7) 福間利英. 自由生活性アメーバNaegleria fowleriが分離された本邦初の原発性アメーバ性髄膜脳炎の症例. 病原微生物検出情報 1997 ; 18 : 8.
 
8) Sugita Y, et al. Primary amebic meningoencephalitis due to Naegleria fowleri : An autopsy case in Japan. Pathol Int 1999 ; 49 : 468-470.
PubMed
9) De Jonckheere JF, et al. First isolation of pathogenic Naegleria fowleri in Japan. Jpn J Parasitol 1991 ; 40 : 352-357.
 
10) 福間利英. 自由生活性アメーバ性脳炎. 感染・炎症・免疫 2012 ; 42 (2) : 173-177.
 
11) Hara T, Fukuma T. Diagnosis of the primary amoebic meningoencephalitis due to Naegleria fowreli. Parasitol Int 2005 ; 54 : 219-221.
PubMed
12) Seidei JS, et al. Successful treatment of primary amebic meningoencephalitis. N Engl J Med 1982 ; 306 : 346-348.
 
13) Brown RL. Successful treatment of primary amebic meningoencephalitis. Arch Intern Med 1991 ; 151 : 1201-1202.
PubMed
14) Valgas-Zepeda J, et al. Successful treatment of Nagleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin. Arch Med Res 2005 ; 36 : 83-86.
 
・ Reed SL. Amebiasis and infection with free-living amebas. In : Fauci AS, et al (editors). Harrison's Principles of Internal Medicine, 17th edition. NY : McGraw-Hill ; 2008, pp.1275-1280.
 
・ Moore TA. Agents used to treat parasitic infections. ibid. pp.1270-1275.
 
P.261 掲載の参考文献
1) Woodhall D, et al. Neglected parasitic infections : What every family physician needs to know. Am Fam Physician 2014 ; 89 : 803-811.
PubMed
2) 吉田彩子ほか. 動物由来回虫類感染症のわが国における最近の動向. Clinical Parasitology 2012 ; 23 : 105-108.
 
3) Umehara F, et al. MRI studies of spinal visceral larva migrans syndrome. J Neurol Sci 2006 ; 249 : 7-12.
PubMed
4) 熱帯病治療薬研究班 (編). 寄生虫症薬物治療の手引き, 2014, 改訂8.1版. http://trop-parasit.jp/docDL/tebiki_2014ver81.pdf
 
5) Graeff-Teixeira C, et al. Update on eosinophilic meningoencephalitis and its clinical relevance. Clin Microbiol Rev 2009 ; 22 : 322-348.
PubMed
6) 吉村堅太郎. 広東住血線虫症. 感染症の話 (感染症情報センター). 国立感染症研究所 ; 2004. http://idsc.nih.go.jp/idwr/kansen/k04/k04_25.html
 
7) Katchanov J, et al. Neurognathostomiasis, a neglected parasitosis of the central nervous system. Emerg Infect Dis 2011 ; 17 : 1174-1180.
PubMed
8) Sawanyawisuth K, et al. Sequential imaging studies of cerebral gnathostomiasis with subdural hemorrhage as its complication. Trans R Soc Trop Med Hyg 2009 ; 103 : 102-104.
PubMed
9) Herman JS, Chiodini PL. Gnathostomiasis, another emerging imported disease. Clin Microbiol Rev 2009 ; 22 : 484-492.
PubMed
10) Kazacos KR, et al. Baylisascaris larva migrans. Handb Clin Neurol 2013 ; 114 : 251-262.
PubMed
11) Eberhardt O, et al. Eosinophilic meningomyelitis in toxocariasis : Case report and review of the literature. Clin Neurol Neurosurg 2005 ; 107 : 432-438.
PubMed
P.266 掲載の参考文献
1) Finsterer J, Auer H. Parasitoses of the human central nervous system. J Helminthol 2013 ; 87 : 257-270.
PubMed
2) Garcia HH, et al. Neurocysticercosis : Some of the essentials. Pract Neurol 2006 ; 6 : 288-297.
 
3) Del Brutto OR, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001 ; 57 : 177-183.
 
4) Nakamura-Uchiyama F, et al. An Imported case of disseminated cysticercosis and taeniasis. Intern Med 2012 ; 51 : 347-348.
PubMed
5) Abdel Razek AA, et al. Parasitic diseases of the central nervous system. Neuroimaging Clin N Am 2011 ; 21 : 815-841.
PubMed
6) Garcia HH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004 ; 350 : 249-258.
PubMed
7) Hughes AJ, Biggs BA. Parasitic worms of the central nervous system : An Australian perspective. Intern Med J 2002 ; 32 : 541-553.
PubMed
8) Nobayashi M, et al. Surgical removal of a live worm by stereotactic targeting in cerebral sparganosis. Case report. Neurol Med Chir (Tokyo) 2006 ; 46 : 164-167.
PubMed
9) Kantarci M, et al. Alveolar echinococcosis : Spectrum of findings at cross-sectional imaging. Radiographics 2012 ; 32 : 2053-2070.
PubMed
10) Senturk S, et al. Cerebral alveolar echinoccosis mimicking primary brain tumor. AJNR Am J Neuroradiol 2006 ; 27 : 420-422.
PubMed
11) Tappe D, et al. Brain and lung metastasis of alveolar echinococcosis in a refugee from a hyperendemic area. J Med Microbiol 2008 ; 57 : 1420-1423.
 
12) Algros MP, et al. Intracerebral alveolar echinococcosis. Infection 2003 ; 31 : 63-65.
PubMed
13) Wang J, et al. Surgical treatment options for cerebral alveolar echinococcosis : Experience in six patient. Neurol India 2009 ; 57 : 157-161.
PubMed
14) Altas M, et al. A medically treated multiple cerebral hydatid cyst disease. J Neurosurg Sci 2010 ; 54 : 79-82.
 
15) Bukte Y, et al. Cerebral hydatid disease : CT and MR imaging findings. Swiss Med Wkly 2004 ; 134 : 459-467.
 
16) Haliloglu M, et al. Spectrum of imaging findings in pediatric hydatid disease. Am J Roentgenol 1997 ; 169 : 1627-1631.
 
17) El-Shamam O, et al. Magnetic resonance imaging of simple and infected hydatid cysts of the brain. Magn Reson Imaging 2001 ; 19 : 965-974.
 
18) Beskonakli E, et al. Primary intracranial extradural hydatid cyst extending above and below the tentorium. Br J Neurosurg 1996 ; 10 : 315-316.
PubMed
P.272 掲載の参考文献
1) Katchanov J, Nawa Y. Helminthic invasion of the central nervous system : Many roads lead to Rome. Parasitol Int 2010 ; 59 : 491-496.
PubMed
2) 関島良樹ほか. 脳宮崎肺吸虫症のMRI所見. 神経内科 1999 ; 51 : 578-580.
 
3) 鶴岡純一郎ほか. 脳病変を契機に診断に至ったウェステルマン肺吸虫による脳肺吸虫症の1例. 小児感染免疫 2012 ; 24 : 19-23.
 
4) 吉岡進ほか. 慢性期脳肺吸虫症の神経放射線学的検討. 大分県立病院医学雑誌 2000 ; 29 : 138-140.
 
5) 中村 (内山) ふくみほか. 肺外病変を主とした肺吸虫症の3例. Clin Parasitol 2004 ; 15 : 40-43.
 
6) 千種雄一. その他の吸虫症 (肺吸虫症, 肝吸虫症, 横川吸虫症, 肝蛭症). 山口徹 (編), 今日の治療指針 2012 -私はこう治療している, Vol.54. 東京 : 医学書院 ; 2012, pp.251-252.
 
7) 熱帯病治療薬研究班. 寄生虫薬物治療の手引き 2010. [Cited 3rd. March 2014] http://trop-parasit.jp/
 
8) Lambertucci JR, et al. Guidelines for the diagnosis and treatment of schistosomal myeloradiculopathy. Rev Soc Bras Med Trop 2007 ; 40 : 574-581.
PubMed
9) Carod-Artal FJ. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 2008 ; 102 : 107-116.
PubMed
10) Ferrari TCA. A laboratory test for the diagnosis of neuroschistosomiasis. Neurol Res 2010 ; 32 : 252-262.
PubMed
11) 伊藤研悠, 大脇義宏. 住血吸虫症性脊髄炎の1例. 東海脊椎外科 2009 ; 23 : 23-27.
 
12) Sturrock RF. The parasites and their life cycles. In : Jordan P, et al (editors). Human Schistosomiasis. Wallingford : CAB International ; 1993, pp.1-32.
 
13) 林正高. 日本住血吸虫症の臨床. 大鶴正満ほか (監修), 日本における寄生虫学の研究. 東京 : 目黒寄生虫館 ; 1999, pp.63-80.
 
14) Zhou J, et al. Cerebral schistosomiasis japonica without gastrointestinal system involvement. Surg Neurol 2009 ; 71 : 481-486.
PubMed
15) Imai K, et al. Cerebral schistosomiasis due to Schistosoma haematobium confirmed by PCR analysis of brain specimen. J Clin Microbiol 2011 ; 49 : 3703-3706.
PubMed
16) Kato-Hayashi N, et al. Use of cell-free circulating schistosome DNA in serum, urine, semen, and saliva to monitor a case of refractory imported schistosomiasis haematobia. J Clin Microbiol 2013 ; 51 : 3435-3438.
 
17) Harter G, et al. Diagnosis of neuroschistosomiasis by antibody specificity index and semi-quantitative real-time PCR from cerebrospinal fluid and serum. J Med Microbiol 2014 ; 63 : 309-312.
 
18) 千種雄一. 住血吸虫症. 山口徹 (編), 今日の治療指針 2011 -私はこう治療している, Vol.53. 東京 : 医学書院 ; 2011, pp.263.
 
P.275 掲載の参考文献
1) 熱帯病治療薬研究班. 寄生虫症薬物治療の手引き 2014. http://trop-parasit.jp/
 
2) Marin B, et al. Onchocerciasis-related epilepsy? Prospects at a time of uncertainty. Trends Parasitol 2006 ; 22 : 17-20.
 
3) Pion SDS, et al. Epilepsy in onchocerciasis endemic areas : Systematic review and meta-analysis of population-based surveys. PLoS Negl Trop Dis 2009 ; 3 (6) : e461.
PubMed
4) Duke BOL, et al. Microfilariae in the cerebrospinal fluid, and neurological complications, during treatment of onchocerciasis with diethylcarbamazine. Tropenmed Parasitol 1976 ; 27 : 123-132.
 
5) Winkler AS, et al. The head nodding syndrome--Clinical classification and possible causes. Epilepsia 2008 ; 49 : 2008-2015.
PubMed
6) Taiwo SS, Tamiowo MO. Loa loa meningoencephalitis in Southwestern Nigeria. West Afr J Med 2007 ; 26 : 156-159.
PubMed
7) Kamgno J, et al. Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp. Am J Trop Med Hyg 2008 ; 78 : 546-551.
 
8) Gobbi F, et al. Case report : Loiasis with peripheral nerve involvement and spleen lesions. Am J Trop Med Hyg 2011 ; 84 : 733-737.
PubMed
9) Garg RK, et al. Pott's paraplegia like presentation : A neurological complication of lymphatic filariasis. J Assoc Physicians India 1996 ; 44 : 741-742.
PubMed
10) Paliwal VK, et al. Acute disseminated encephalomyelitis following filarial infection. J Neurol Neurosurg Psychiatry 2012 ; 83 : 347-349.
PubMed
11) Akao N. Human dirofilariasis in Japan. In : Asian Parasitology, Vol. 3, Filariasis in Asia and Western Pacific Islands. Chiba : AAA Committee, The Federation of Asian Parasitologists ; 2005, pp.145-152.
 
12) 関根鉄朗ほか. イヌ糸状虫抗体価上昇を認めた好酸球性髄膜炎の1例. Neuroinfection 2006 ; 11 : 38.
 
13) 藤井裕樹ほか. フィラリア感染に関連した脊髄症の一例. Neuroinfection 2006 ; 11 : 40.
 
14) Dobson C, Welch JS. Dirofilariasis as a cause of eosinophilic meningitis in man diagnosed by immunofluorescence and Arthus hypersensitivity. Trans R Soc Trop Med Hyg 1974 ; 68 : 223-228.
PubMed
15) Genchi C, et al. Dirofilaria infections in Europe. Vector Borne Zoonotic Dis 2011 ; 11 : 1307-1317.
PubMed
16) 物部寛子ほか. Dirofilaria repens感染による皮下結節症例. Clinical Parasitology 2012 ; 23 : 49-52.
 
17) Poppert S, et al. Dirofilaria repens infection and concomitant meningoencephalitis. Emerg Infect Dis 2009 ; 15 : 1844-1846.
PubMed

VII. プリオン病

P.285 掲載の参考文献
1) Riesner D. Biochemistry and structure of PrP (C) and PrP (Sc). Br Med Bull 2003 ; 66 : 21-33.
 
2) Huang Z, et al. Scrapie prions : A three-dimensional model of an infectious fragment. Fold Des 1995 ; 1 (1) : 13-19.
PubMed
3) Oesch B, et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell 1985 ; 40 (4) : 735-746.
PubMed
4) Dalsgaard NJ. Prion diseases. An overview. APMIS 2002 ; 110 (1) : 3-13.
PubMed
5) Parchi P, et al. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996 ; 39 (6) : 767-778.
PubMed
6) Parchi P, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999 ; 46 (2) : 224-233.
 
7) Kovacs GG, et al. Genetic prion disease : The EUROCJD experience. Hum Genet 2005 ; 118 (2) : 166-174.
PubMed
8) Ladogana A, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology 2005 ; 64 (9) : 1586-1591.
PubMed
9) Higuma M, et al. Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases. PLoS One 2013 ; 8 (3) : e60003.
PubMed
10) Collinge J, et al. Kuru in the 21st century--An acquired human prion disease with very long incubation periods. Lancet 2006 ; 367 (9528) : 2068-2074.
PubMed
11) Noguchi-Shinohara M, et al. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease. Neurology 2007 ; 69 (4) : 360-367.
 
12) Hewitt PE, et al. Creutzfeldt-Jakob disease and blood transfusion : Results of the UK Transfusion Medicine Epidemiological Review study. Vox Sang 2006 ; 91 (3) : 221-230.
PubMed
13) Ward HJ, et al. Variant Creutzfeldt-Jakob disease and exposure to fractionated plasma products. Vox Sang 2009 ; 97 (3) : 207-210.
PubMed
14) Will RG. Acquired prion disease : Iatrogenic CJD, variant CJD, kuru. Br Med Bull 2003 ; 66 : 255-265.
PubMed
15) Gambetti P, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 2008 ; 63 (6) : 697-708.
PubMed
16) Hamaguchi T, et al. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. J Neurol Neurosurg Psychiatry 2013 ; 84 (10) : 1171-1175.
PubMed
17) Kobayashi A, et al. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain. J Biol Chem 2007 ; 282 (41) : 30022-30028.
 
・ 厚生労働科学研究費補助金難治性疾患克服研究事業「プリオン病及び遅発性ウイルス感染症に関する調査研究班」 (編). プリオン病と遅発性ウイルス感染症. 東京 : 金原出版 ; 2010.
 
・ Nozaki I, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain 2010 ; 133 (10) : 3043-3057.
PubMed
・ 橋本順 (編). 特集/知っておきたい認知症の臨床と画像. 臨床放射線 2010 ; 55 (10月増刊号).
 
・ 厚生労働科学研究費補助金・難治性疾患克服研究事業「プリオン病及び遅発性ウイルス感染症に関する調査研究班」 (編). プリオン病感染予防ガイドライン (2008年版) http://prion.umin.jp/guideline/cjd_2008all.pdf
 

Case Study

P.291 掲載の参考文献
1) Martinez AJ, Visvesvara GS. Free-living, amphizoic and opportunistic amebas. Brain Pathol 1997 ; 7 : 583-598.
PubMed
2) Visvesvara GS, et al. Pathogenic and opportunistic free-living amoebae : Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol 2007 ; 50 : 1-26.
PubMed
3) Trabelsi H, et al. Pathogenic free-living amoebae : Epidemiology and clinical review. Pathol Biol 2012 ; 60 : 399-405.
PubMed
P.297 掲載の参考文献
1) Marais S, et al. Tuberculous meningitis : A uniform case definition for use in clinical research. Lancet Infect Dis 2010 ; 10 : 803-812.
PubMed
2) Thwaites GE, et al. Tuberculous meningitis : More questions, still too few answers. Lancet Neurol 2013 ; 12 : 999-1010.
PubMed
3) Thwaites G, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009 ; 59 : 167-187.
 
4) 鈴木裕. 結核性髄膜炎. 別冊日本臨牀, 新領域別症候群シリーズ No.25, 感染症症候群 (第2版) 下. 大阪 : 日本臨牀社 ; 2013, pp.113-119.
 
5) 佐久嶋研ほか. 再注目される感染性髄膜炎の古典的髄液診断マーカー. 臨床神経学 2012 ; 52 : 6-11.
 
6) Nicolls DJ, et al. Intracranial tuberculomas developing while on therapy for pulmonary tuberculosis. Lancet Infect Dis 2005 ; 5 : 795-801.
 
P.304 掲載の参考文献
1) Le Moal G, et al. Characteristics of brain abscess with isolation of anaerobic bacteria. Scand J Infect Dis 2003 ; 35 : 318-321.
PubMed
2) Guppy KH, et al. Cerebral fungal infections in the immunocompromised host : A literature review and a new pathogen--Chaetomium atrobrunneum : Case report. Neurosurgery 1998 ; 43 : 1463-1469.
 
3) Correa D, et al. Antigens and antibodies in sera from human cases of epilepsy or taeniasis from an area of Mexico where Taenia solium cysticercosis is endemic. Ann Trop Med Parasitol 1999 ; 93 : 69-74.
PubMed
4) Reiche W, et al. Differential diagnosis of intracranial ring enhancing cystic mass lesions--Role of diffusionweighted imaging (DWI) and diffusion-tensor imaging (DTI). Clin Neurol Neurosurg 2010 ; 112 : 218-225.
PubMed
5) Mathisen GE, et al. Brain abscess and cerebritis. Rev Infect Dis 1984 ; 6 (Suppl 1) : S101-106.
 
6) Handelsman J. Metagenomics : Application of genomics to uncultured microorganisms. Microbiol Mol Biol Rev 2004 ; 68 : 669-685.
PubMed
7) Petrosino JF, et al. Metagenomic pyrosequencing and microbial identification. Clin Chem 2009 ; 55 : 856-866.
PubMed
8) Sontakke S, et al. Use of broad range16S rDNA PCR in clinical microbiology. J Microbiol Methods 2009 ; 76 : 217-225.
PubMed
9) Hugenholtz P, Tyson GW. Microbiology : Metagenomics. Nature 2008 ; 455 (7212) : 481-483.
PubMed
10) Al Masalma M, et al. The expansion of the microbiological spectrum of brain abscesses with use of multiple 16S ribosomal DNA sequencing. Clin Infect Dis 2009 ; 48 : 1169-1178.
PubMed
11) Yang SY, Zhao CS. Review of 140 patients with brain abscess. Surg Neurol 1993 ; 39 : 290-296.
PubMed
12) Seydoux C, Francioli P. Bacterial brain abscesses : Factors influencing mortality and sequelae. Clin Infect Dis 1992 ; 15 : 394-401.
PubMed
13) Carpenter J, et al. Retrospective analysis of 49 cases of brain abscess and review of the literature. Eur J Clin Microbiol Infect Dis 2007 ; 26 : 1-11.
PubMed
14) Saito N, et al. Culture-negative brain abscess with Streptococcus intermedius infection with diagnosis established by direct nucleotide sequence analysis of the 16s ribosomal RNA gene. Intern Med 2012 ; 51 : 211-216.
PubMed
P.310 掲載の参考文献
1) Keane JR. Multiple cranial nerve palsies : Analysis of 979 cases. Arch Neurol 2005 ; 62 : 1714-1717.
PubMed
2) Yokoseki A, et al. Hypertrophic pachymeningitis : Significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain 2014 ; 137 : 520-536.
PubMed
3) 大越教夫. 肥厚性硬膜炎. 鈴木則宏ほか (編), Annual Review 神経. 東京 : 中外医学社 ; 2012, pp.150-157.
 
4) 植田晃広ほか. 肥厚性硬膜炎の臨床像とステロイド治療法に関する1考察-自験3症例と文献例66症例からの検討. 臨床神経学 2011 ; 51 : 243-247.
 
5) 岡崎和一ほか. IgG4関連疾患包括診断基準 2011. 日本内科学会雑誌 2012 ; 101 : 795-804.
 
P.312 掲載の参考文献
1) 名和行文ほか. 宮崎県下における最近の寄生虫症の動向-うまいもんはこわい. 宮崎県医師会医学会誌別冊 1998 ; 22 : 1-11.
 
2) Osoegawa M, et al. Localised myelitis caused by visceral larva migrans due to Ascaris suum masquerading as an isokated spinal cords tumor. J Neurol Neurosurg Psychiatry 2001 ; 70 : 265-266.
PubMed
3) 吉良潤一. 脳炎・脳症-診断と治療の進歩. 日本内科学会雑誌 2006 ; 95 : 1255-1259.
 
4) Sakakibara A, et al. Visceral larva migarans due to Ascaris suum which presented with eosinophilic pneumonia and multiple intra-hepatic lesions with severe eosinophil infiltration. Intern Med 2002 ; 41 : 58-59.
 
5) 吉田園代ほか. ブタ回虫幼虫移行症によるmyeloradiculitisを呈した1例. 臨床神経学 2004 ; 44 : 198-202.
 
6) 中村ふくみ, 名和行文. 寄生虫症における血清診断の活かし方. 治療学 2003 ; 37 : 597-601.
 
P.317 掲載の参考文献
1) Durack DT, Street AC. Fever of unknown origin--reexamined and redefined. Curr Clin Top Infect Dis 1991 ; 11 : 35-51.
PubMed
2) Mourad O, et al. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 2003 ; 163 : 545-551.
PubMed
3) Bickels J, et al. Primary pyomyositis. J Bone Joint Surg Am 2002 ; 84 : 2277-2286.
PubMed
4) Mallick IH, et al. Iliopsoas abscesses. Postgrad Med J 2004 ; 80 : 459-462.
PubMed
5) Crum-Cianflone NF. Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev 2008 ; 21 : 473-494.
PubMed
6) Otake S. Sarcoidosis involving skeletal muscle : Imaging findings and relative value of imaging procedures. AJR Am J Roentgenol 1994 ; 162 : 369-375.
PubMed
7) 熊本俊秀. 感染性筋炎. Clinical Neuroscience 2010 ; 28 : 340-342.
 

付録

P.329 掲載の参考文献
1) 日本神経感染症学会. ヘルペス脳炎のガイドライン. Neuroinfection 2005 ; 10 : 78-87. 単純ヘルペス脳炎診療ガイドライン http://www.neuroinfection.jp/guideline001.html
 
2) 日本神経感染症学会 (編). ヘルペス脳炎-診療ガイドラインに基づく診断基準と治療指針. 東京 : 中山書店 ; 2006.
 
3) Kamei S, et al. Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis. J Neurol Neurosurg Psychiatry 2005 ; 76 : 1544-1549.
PubMed
4) Solomon T, et al. Viral encephalitis : A clinician's guide. Pract Neurol 2007 ; 7 : 288-305.
PubMed
5) Tunkel AR, et al. The management of encephalitis : Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008 ; 47 : 303-327.
 
6) Martinez-Torres F, et al. Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplexvirus-encephalitis (GACHE) : A multicenter, multinational, randomized, double-blind, placebocontrolled German, Austrian and Dutch trial. BMC Neurol 2008 ; 8 : 40.
 
8) Solomon T, et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012 ; 64 : 347-373.
 
9) Granerod J, et al. Causes of encephalitis and differences in their clinical presentations in England : A multicentre, population-based prospective study. Lancet Infect Dis 2010 ; 10 : 835-844.
 
7 Cinque P, et al. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis : A consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry 1996 ; 61 : 339-345.
PubMed
P.333 掲載の参考文献
1) Hsu HE, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009 ; 360 (3) : 244-256.
PubMed
2) Morita A, et al. Open-label study to evaluate the pharmacodynamics, clinical efficacy, and safety of meropenem for adult bacterial meningitis in Japan. J Infect Chemother 2014 ; 20 (9) : 535-540.
PubMed
3) 高橋恵子ほか. 院内感染による細菌性髄膜炎本邦成人例における起炎菌と転帰影響要因. 臨床神経学 2013 ; 53 : 1461.
 
P.337 掲載の参考文献
1) Chiller TM, et al. Clinical findings for fungal infections caused by methylprednisolone injections. N Engl J Med 2013 ; 369 (17) : 1610-1619.
PubMed
2) Smith RM, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med 2013 ; 369 (17) : 1598-1609.
PubMed
3) Liu TB, et al. Molecular mechanisms of cryptococcal meningitis. Virulence 2012 ; 3 (2) : 173-181.
PubMed
4) 深在性真菌症のガイドライン作成委員会 (編). 深在性真菌症の診断・治療ガイドライン 2014. 東京 : 協和企画 ; 2014.
 
5) Perfect JR, et al. Clinical practice guidelines for the management of cryptococcal disease : 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2010 ; 50 : 291-322.
 
6) 日本神経治療学会, 日本神経学会, 日本神経感染症学会 (監), 細菌性髄膜炎の診療ガイドライン作成委員会 (編). 細菌性髄膜炎のガイドライン. 神経治療学 2007 ; 24 : 3-64.
 
7) Park BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV / AIDS. AIDS 2009 ; 23 : 525-530.
PubMed
8) Sun HY, et al. Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients : Evidence-based evolving trends. Clin Infect Dis 2009 ; 48 : 1566-1576.
PubMed
9) Husain S, et al. Cryptococcus neoformans infection in organ transplant recipients : Variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001 ; 7 : 375-381.
PubMed
10) Vilchez RA, et al. Cryptococcosis in organ transplant recipients : An overview. Am J Transplant 2002 ; 2 : 575-580.
PubMed
11) Galanis E, et al ; British Columbia Cryptococcus gattii Working Group. Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerg Infect Dis 2010 ; 16 : 251-257.
 
12) Okamoto K, et al. Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg Infect Dis 2010 ; 16 : 1155-1157.
PubMed
13) Hagen F, et al. In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates. Antimicrob Agents Chemother 2010 ; 54 : 5139-5145.
PubMed
14) Antinori S, et al. Aspergillus meningitis : A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect 2013 ; 66 : 218-238.
 
15) Walsh TJ, et al. Treatment of aspergillosis : Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008 ; 46 : 327-360.
 
16) Pappas PG, et al. Clinical practice guidelines for the management of candidiasis : 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009 ; 48 : 503-535.
 
17) Roden MM, et al. Epidemiology and outcome of zygomycosis : A review of 929 reported cases. Clin Infect Dis 2005 ; 41 (5) : 634-653.
PubMed

書評

最近チェックした商品履歴

Loading...